Corporate Lobbying News | Quiver Quantitative

Lobbying Update: $30,000 of NEWSMAX lobbying was just disclosed

13 hours ago | Feb. 13, 2026 9:03 p.m. UTC

$30,000 of NEWSMAX lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Matters relating to TV broadcasting."

You can find more data on corporate lobbying on Quiver Quantitative.

NMAX Hedge Fund Activity

We have seen 84 institutional investors add shares of NMAX stock to their portfolio, and 65 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

GREENWICH WEALTH MANAGEMENT LLC added 22,795,352 shares (+inf%) to their portfolio in Q4 2025, for an estimated $176,208,070
BLACKROCK, INC. added 1,906,588 shares (+353.0%) to their portfolio in Q4 2025, for an estimated $14,737,925
STATE STREET CORP added 527,126 shares (+520.9%) to their portfolio in Q4 2025, for an estimated $4,074,683
GEODE CAPITAL MANAGEMENT, LLC added 440,577 shares (+329.1%) to their portfolio in Q4 2025, for an estimated $3,405,660
GOLDMAN SACHS GROUP INC added 418,199 shares (+1033.1%) to their portfolio in Q4 2025, for an estimated $3,232,678
UBS GROUP AG added 412,173 shares (+4495.3%) to their portfolio in Q4 2025, for an estimated $3,186,097
SOVIERO ASSET MANAGEMENT, LP added 235,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $2,914,000

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NMAX Analyst Ratings

Wall Street analysts have issued reports on $NMAX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Noble Capital Markets issued a "Outperform" rating on 08/21/2025

To track analyst ratings and price targets for NMAX, check out Quiver Quantitative's $NMAX forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $15,000 of AXOGEN CORPORATION lobbying was just disclosed

13 hours ago | Feb. 13, 2026 9:03 p.m. UTC

$15,000 of AXOGEN CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"issues related to development of medical products"

You can find more data on corporate lobbying on Quiver Quantitative.

AXGN Insider Trading Activity

AXGN insiders have traded $AXGN stock on the open market 36 times in the past 6 months. Of those trades, 0 have been purchases and 36 have been sales.

Here’s a breakdown of recent trading of $AXGN stock by insiders over the last 6 months:

WILLIAM P. MR. BURKE has made 0 purchases and 13 sales selling 132,463 shares for an estimated $2,821,444.
MICHAEL D DALE (Chief Executive Officer) has made 0 purchases and 2 sales selling 86,463 shares for an estimated $2,668,137.
JOHN JOHNSON has made 0 purchases and 4 sales selling 45,379 shares for an estimated $1,390,392.
KATHY JOHNSON WEILER has made 0 purchases and 3 sales selling 46,653 shares for an estimated $1,378,475.
AMY MCBRIDE WENDELL has made 0 purchases and 3 sales selling 43,684 shares for an estimated $1,280,465.
LINDSEY MARIE HARTLEY (CFO) has made 0 purchases and 3 sales selling 29,199 shares for an estimated $896,298.
JOSEPH A. TYNDALL has made 0 purchases and 2 sales selling 25,108 shares for an estimated $777,770.
MARC A BEGAN (EVP & General Counsel) has made 0 purchases and 2 sales selling 22,500 shares for an estimated $686,207.
PAUL THOMAS sold 21,399 shares for an estimated $633,709
ERICK WAYNE DEVINNEY (Chief Innovation Officer) has made 0 purchases and 2 sales selling 20,654 shares for an estimated $627,608.
JENS KEMP (Chief Marketing Officer) sold 8,156 shares for an estimated $254,532

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AXGN Hedge Fund Activity

We have seen 115 institutional investors add shares of AXGN stock to their portfolio, and 92 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FIRST LIGHT ASSET MANAGEMENT, LLC added 1,276,487 shares (+28.2%) to their portfolio in Q3 2025, for an estimated $22,772,528
WASATCH ADVISORS LP removed 715,779 shares (-43.7%) from their portfolio in Q4 2025, for an estimated $23,427,446
BROWN CAPITAL MANAGEMENT LLC added 644,623 shares (+inf%) to their portfolio in Q3 2025, for an estimated $11,500,074
BALYASNY ASSET MANAGEMENT L.P. removed 551,516 shares (-28.6%) from their portfolio in Q3 2025, for an estimated $9,839,045
QUBE RESEARCH & TECHNOLOGIES LTD removed 545,153 shares (-74.8%) from their portfolio in Q3 2025, for an estimated $9,725,529
SOLEUS CAPITAL MANAGEMENT, L.P. removed 519,698 shares (-30.1%) from their portfolio in Q4 2025, for an estimated $17,009,715
MARSHALL WACE, LLP removed 454,126 shares (-70.8%) from their portfolio in Q3 2025, for an estimated $8,101,607

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AXGN Analyst Ratings

Wall Street analysts have issued reports on $AXGN in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

HC Wainwright & Co. issued a "Buy" rating on 12/05/2025
Mizuho issued a "Outperform" rating on 12/01/2025
Canaccord Genuity issued a "Buy" rating on 10/30/2025
Citizens issued a "Market Outperform" rating on 10/30/2025
Raymond James issued a "Outperform" rating on 10/30/2025

To track analyst ratings and price targets for AXGN, check out Quiver Quantitative's $AXGN forecast page.

AXGN Price Targets

Multiple analysts have issued price targets for $AXGN recently. We have seen 7 analysts offer price targets for $AXGN in the last 6 months, with a median target of $37.0.

Here are some recent targets:

Caitlin Cronin from Canaccord Genuity set a target price of $37.0 on 12/05/2025
Yi Chen from HC Wainwright & Co. set a target price of $39.0 on 12/05/2025
Frank Takkinen from Lake Street set a target price of $40.0 on 12/04/2025
Michael Sarcone from Jefferies set a target price of $36.0 on 12/04/2025
Anthony Petrone from Mizuho set a target price of $40.0 on 12/01/2025
David Turkaly from Citizens set a target price of $34.0 on 10/30/2025
Jayson Bedford from Raymond James set a target price of $27.0 on 10/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $180,000 of SHOPIFY INC lobbying was just disclosed

1 day, 10 hours ago | Feb. 13, 2026 12:03 a.m. UTC

$180,000 of SHOPIFY INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to the growth of independent small businesses in the digital economy. Issues related to online government resources for small businesses, including support for the One Stop Shop for Small Business Licensing Act. Issues related to modernizing small business grants and mentoring to promote a greater focus on e-commerce. Issues related to combating online sale of counterfeit goods. Issues related to consumer privacy. Issues related to the reform of laws relating to the protection of intellectual property rights. Issues related to competition in the market for credit card routing, including support for The Credit Card Competition Act. Issues related to Self-Employment Assistance programs and removing barriers to entrepreneurship in unemployment insurance, including support for The NO BOSS Act. Issues related to accessibility standards for website design. Issues related to artificial intelligence and its benefits for small business. Issues related to the regulation of financial technology. Issues related to small business and corporate tax reform. Issues related to the impact of tariffs and changes to the de minimis exemption on small businesses."

You can find more data on corporate lobbying on Quiver Quantitative.

SHOP Congressional Stock Trading

Members of Congress have traded $SHOP stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $SHOP stock by members of Congress over the last 6 months:

REPRESENTATIVE JONATHAN L. JACKSON has traded it 3 times. They made 3 purchases worth up to $165,000 on 12/08, 10/08, 10/06 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

SHOP Hedge Fund Activity

We have seen 824 institutional investors add shares of SHOP stock to their portfolio, and 805 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL RESEARCH GLOBAL INVESTORS removed 7,594,495 shares (-79.8%) from their portfolio in Q4 2025, for an estimated $1,222,485,860
WCM INVESTMENT MANAGEMENT, LLC added 6,700,679 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,078,608,298
CAPITAL WORLD INVESTORS removed 5,789,891 shares (-10.8%) from their portfolio in Q4 2025, for an estimated $931,998,754
PRICE T ROWE ASSOCIATES INC /MD/ removed 5,240,796 shares (-16.5%) from their portfolio in Q3 2025, for an estimated $778,834,693
BAILLIE GIFFORD & CO removed 4,237,555 shares (-12.0%) from their portfolio in Q4 2025, for an estimated $682,119,228
POLEN CAPITAL MANAGEMENT LLC removed 3,859,034 shares (-34.9%) from their portfolio in Q4 2025, for an estimated $621,188,702
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 3,584,441 shares (-30.1%) from their portfolio in Q3 2025, for an estimated $532,683,777

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SHOP Analyst Ratings

Wall Street analysts have issued reports on $SHOP in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Mizuho issued a "Outperform" rating on 02/12/2026
Needham issued a "Buy" rating on 02/12/2026
Scotiabank issued a "Sector Outperform" rating on 01/08/2026
Morgan Stanley issued a "Overweight" rating on 11/05/2025
BMO Capital issued a "Outperform" rating on 11/05/2025
JP Morgan issued a "Overweight" rating on 11/05/2025
CIBC issued a "Outperformer" rating on 11/05/2025

To track analyst ratings and price targets for SHOP, check out Quiver Quantitative's $SHOP forecast page.

SHOP Price Targets

Multiple analysts have issued price targets for $SHOP recently. We have seen 23 analysts offer price targets for $SHOP in the last 6 months, with a median target of $170.0.

Here are some recent targets:

Thanos Moschopoulos from BMO Capital set a target price of $160.0 on 02/12/2026
Trevor Young from Barclays set a target price of $130.0 on 02/12/2026
Andrew Boone from Citizens set a target price of $160.0 on 02/12/2026
Terry Tillman from Truist Securities set a target price of $110.0 on 02/12/2026
Timothy Chiodo from UBS set a target price of $145.0 on 02/12/2026
Scott Berg from Needham set a target price of $180.0 on 02/12/2026
Paul Treiber from RBC Capital set a target price of $170.0 on 02/12/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $70,000 of COEUR MINING INC. lobbying was just disclosed

1 day, 13 hours ago | Feb. 12, 2026 9:04 p.m. UTC

$70,000 of COEUR MINING INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"mining, federal lands issues"

You can find more data on corporate lobbying on Quiver Quantitative.

CDE Insider Trading Activity

CDE insiders have traded $CDE stock on the open market 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CDE stock by insiders over the last 6 months:

MITCHELL J KREBS (Chairman, President and CEO) has made 0 purchases and 2 sales selling 250,000 shares for an estimated $3,651,250.
CASEY M. NAULT (SVP, GC & Secretary) sold 102,257 shares for an estimated $1,227,084
KENNETH J WATKINSON (VP, Corporate Controller & CAO) sold 22,001 shares for an estimated $331,115
PARAMITA DAS purchased 385 shares for an estimated $4,454

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CDE Hedge Fund Activity

We have seen 267 institutional investors add shares of CDE stock to their portfolio, and 240 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

VAN ECK ASSOCIATES CORP added 23,646,265 shares (+55.8%) to their portfolio in Q3 2025, for an estimated $443,603,931
NORGES BANK added 6,680,393 shares (+1283.9%) to their portfolio in Q4 2025, for an estimated $119,111,407
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. added 6,352,828 shares (+36.3%) to their portfolio in Q3 2025, for an estimated $119,179,053
GOLDMAN SACHS GROUP INC added 6,012,718 shares (+92.6%) to their portfolio in Q4 2025, for an estimated $107,206,761
PRICE T ROWE ASSOCIATES INC /MD/ added 5,028,336 shares (+114.3%) to their portfolio in Q3 2025, for an estimated $94,331,583
VOLORIDGE INVESTMENT MANAGEMENT, LLC removed 4,008,776 shares (-83.3%) from their portfolio in Q3 2025, for an estimated $75,204,637
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 3,982,085 shares (+38.6%) to their portfolio in Q3 2025, for an estimated $74,703,914

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CDE Analyst Ratings

Wall Street analysts have issued reports on $CDE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

TD Securities issued a "Buy" rating on 11/11/2025

To track analyst ratings and price targets for CDE, check out Quiver Quantitative's $CDE forecast page.

CDE Price Targets

Multiple analysts have issued price targets for $CDE recently. We have seen 3 analysts offer price targets for $CDE in the last 6 months, with a median target of $25.0.

Here are some recent targets:

Josh Wolfson from RBC Capital set a target price of $26.0 on 02/12/2026
Joe Reagor from Roth Capital set a target price of $23.0 on 12/15/2025
Wayne Lam from TD Securities set a target price of $25.0 on 11/11/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $60,000 of KILROY REALTY lobbying was just disclosed

4 days, 4 hours ago | Feb. 10, 2026 6:01 a.m. UTC

$60,000 of KILROY REALTY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"VISN 21 VA facilities modernization Marine Corps Air Station Miramar flight regulations Corporate State and Local Tax Deduction"

You can find more data on corporate lobbying on Quiver Quantitative.

KRC Hedge Fund Activity

We have seen 214 institutional investors add shares of KRC stock to their portfolio, and 150 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

D1 CAPITAL PARTNERS L.P. added 6,595,654 shares (+349.5%) to their portfolio in Q3 2025, for an estimated $278,666,381
CANADA PENSION PLAN INVESTMENT BOARD removed 2,839,216 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $119,956,876
M&T BANK CORP added 2,748,704 shares (+34820.2%) to their portfolio in Q4 2025, for an estimated $102,719,068
FMR LLC added 2,672,323 shares (+61.1%) to their portfolio in Q3 2025, for an estimated $112,905,646
DEUTSCHE BANK AG\ added 2,167,412 shares (+3356.0%) to their portfolio in Q3 2025, for an estimated $91,573,157
PRUDENTIAL FINANCIAL INC removed 1,672,685 shares (-98.4%) from their portfolio in Q3 2025, for an estimated $70,670,941
ROUTE ONE INVESTMENT COMPANY, L.P. added 1,618,711 shares (+161.7%) to their portfolio in Q3 2025, for an estimated $68,390,539

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

KRC Analyst Ratings

Wall Street analysts have issued reports on $KRC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

Jefferies issued a "Buy" rating on 10/13/2025
Scotiabank issued a "Sector Underperform" rating on 08/28/2025
Goldman Sachs issued a "Sell" rating on 08/21/2025

To track analyst ratings and price targets for KRC, check out Quiver Quantitative's $KRC forecast page.

KRC Price Targets

Multiple analysts have issued price targets for $KRC recently. We have seen 10 analysts offer price targets for $KRC in the last 6 months, with a median target of $43.0.

Here are some recent targets:

Nicholas Yulico from Scotiabank set a target price of $42.0 on 01/14/2026
Vikram Malhotra from Mizuho set a target price of $37.0 on 12/12/2025
Brendan Lynch from Barclays set a target price of $42.0 on 12/01/2025
Blaine Heck from Wells Fargo set a target price of $41.0 on 11/25/2025
John Kim from BMO Capital set a target price of $44.0 on 11/18/2025
Steve Sakwa from Evercore ISI Group set a target price of $46.0 on 11/14/2025
Michael Carroll from RBC Capital set a target price of $47.0 on 11/03/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $90,000 of FREEDOM HOLDING CORP lobbying was just disclosed

4 days, 16 hours ago | Feb. 9, 2026 6:02 p.m. UTC

$90,000 of FREEDOM HOLDING CORP lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Support for the development of critical minerals in Kazakhstan. HR 1024, US-Kazakhstan Trade Modernization Act. Matters relating to financial services."

You can find more data on corporate lobbying on Quiver Quantitative.

FRHC Insider Trading Activity

FRHC insiders have traded $FRHC stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $FRHC stock by insiders over the last 6 months:

SERGEY LUKYANOV (*See Remarks) purchased 5,725 shares for an estimated $982,810
AZAMAT YERDESSOV (Freedom Life Chief Exec. Ofc.) sold 2,007 shares for an estimated $355,239

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

FRHC Hedge Fund Activity

We have seen 78 institutional investors add shares of FRHC stock to their portfolio, and 65 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FIRST TRUST ADVISORS LP added 183,532 shares (+inf%) to their portfolio in Q3 2025, for an estimated $31,591,363
MORGAN STANLEY added 73,088 shares (+59.5%) to their portfolio in Q3 2025, for an estimated $12,580,637
TUDOR INVESTMENT CORP ET AL removed 61,977 shares (-85.9%) from their portfolio in Q3 2025, for an estimated $10,668,101
JPMORGAN CHASE & CO added 49,712 shares (+188.6%) to their portfolio in Q3 2025, for an estimated $8,556,926
CITADEL ADVISORS LLC added 45,876 shares (+177.2%) to their portfolio in Q3 2025, for an estimated $7,896,635
D. E. SHAW & CO., INC. removed 28,246 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $4,861,983
AQR CAPITAL MANAGEMENT LLC added 26,562 shares (+inf%) to their portfolio in Q3 2025, for an estimated $4,572,117

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $15,000 of AXOGEN INC. lobbying was just disclosed

1 week ago | Feb. 6, 2026 9:03 p.m. UTC

$15,000 of AXOGEN INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues relating to sensation loss after mastectomy."

You can find more data on corporate lobbying on Quiver Quantitative.

AXGN Insider Trading Activity

AXGN insiders have traded $AXGN stock on the open market 36 times in the past 6 months. Of those trades, 0 have been purchases and 36 have been sales.

Here’s a breakdown of recent trading of $AXGN stock by insiders over the last 6 months:

WILLIAM P. MR. BURKE has made 0 purchases and 13 sales selling 132,463 shares for an estimated $2,821,444.
MICHAEL D DALE (Chief Executive Officer) has made 0 purchases and 2 sales selling 86,463 shares for an estimated $2,668,137.
JOHN JOHNSON has made 0 purchases and 4 sales selling 45,379 shares for an estimated $1,390,392.
KATHY JOHNSON WEILER has made 0 purchases and 3 sales selling 46,653 shares for an estimated $1,378,475.
AMY MCBRIDE WENDELL has made 0 purchases and 3 sales selling 43,684 shares for an estimated $1,280,465.
LINDSEY MARIE HARTLEY (CFO) has made 0 purchases and 3 sales selling 29,199 shares for an estimated $896,298.
JOSEPH A. TYNDALL has made 0 purchases and 2 sales selling 25,108 shares for an estimated $777,770.
MARC A BEGAN (EVP & General Counsel) has made 0 purchases and 2 sales selling 22,500 shares for an estimated $686,207.
PAUL THOMAS sold 21,399 shares for an estimated $633,709
ERICK WAYNE DEVINNEY (Chief Innovation Officer) has made 0 purchases and 2 sales selling 20,654 shares for an estimated $627,608.
JENS KEMP (Chief Marketing Officer) sold 8,156 shares for an estimated $254,532

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AXGN Hedge Fund Activity

We have seen 97 institutional investors add shares of AXGN stock to their portfolio, and 82 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FIRST LIGHT ASSET MANAGEMENT, LLC added 1,276,487 shares (+28.2%) to their portfolio in Q3 2025, for an estimated $22,772,528
BROWN CAPITAL MANAGEMENT LLC added 644,623 shares (+inf%) to their portfolio in Q3 2025, for an estimated $11,500,074
BALYASNY ASSET MANAGEMENT L.P. removed 551,516 shares (-28.6%) from their portfolio in Q3 2025, for an estimated $9,839,045
QUBE RESEARCH & TECHNOLOGIES LTD removed 545,153 shares (-74.8%) from their portfolio in Q3 2025, for an estimated $9,725,529
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 459,707 shares (+1578.6%) to their portfolio in Q3 2025, for an estimated $8,201,172
MARSHALL WACE, LLP removed 454,126 shares (-70.8%) from their portfolio in Q3 2025, for an estimated $8,101,607
SQUAREPOINT OPS LLC removed 407,671 shares (-84.3%) from their portfolio in Q3 2025, for an estimated $7,272,850

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AXGN Analyst Ratings

Wall Street analysts have issued reports on $AXGN in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

HC Wainwright & Co. issued a "Buy" rating on 12/05/2025
Mizuho issued a "Outperform" rating on 12/01/2025
Canaccord Genuity issued a "Buy" rating on 10/30/2025
Citizens issued a "Market Outperform" rating on 10/30/2025
Raymond James issued a "Outperform" rating on 10/30/2025

To track analyst ratings and price targets for AXGN, check out Quiver Quantitative's $AXGN forecast page.

AXGN Price Targets

Multiple analysts have issued price targets for $AXGN recently. We have seen 7 analysts offer price targets for $AXGN in the last 6 months, with a median target of $37.0.

Here are some recent targets:

Yi Chen from HC Wainwright & Co. set a target price of $39.0 on 12/05/2025
Caitlin Cronin from Canaccord Genuity set a target price of $37.0 on 12/05/2025
Frank Takkinen from Lake Street set a target price of $40.0 on 12/04/2025
Michael Sarcone from Jefferies set a target price of $36.0 on 12/04/2025
Anthony Petrone from Mizuho set a target price of $40.0 on 12/01/2025
David Turkaly from Citizens set a target price of $34.0 on 10/30/2025
Jayson Bedford from Raymond James set a target price of $27.0 on 10/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $15,000 of SENSUS HEALTHCARE INC. lobbying was just disclosed

1 week ago | Feb. 6, 2026 6:02 p.m. UTC

$15,000 of SENSUS HEALTHCARE INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"medicare fee schedule and coverage for skin cancer treatments"

You can find more data on corporate lobbying on Quiver Quantitative.

SRTS Insider Trading Activity

SRTS insiders have traded $SRTS stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $SRTS stock by insiders over the last 6 months:

JOSEPH C SARDANO (CHIEF EXECUTIVE OFFICER) purchased 25,000 shares for an estimated $100,750
ERIC SACHETTA has made 2 purchases buying 9,500 shares for an estimated $38,760 and 0 sales.
MICHAEL SARDANO (PRESIDENT AND GENERAL COUNSEL) has made 3 purchases buying 3,000 shares for an estimated $11,430 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

SRTS Hedge Fund Activity

We have seen 13 institutional investors add shares of SRTS stock to their portfolio, and 24 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 668,880 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,100,283
PERRITT CAPITAL MANAGEMENT INC removed 469,692 shares (-78.9%) from their portfolio in Q3 2025, for an estimated $1,474,832
ACADIAN ASSET MANAGEMENT LLC removed 148,282 shares (-39.3%) from their portfolio in Q3 2025, for an estimated $465,605
DIVISADERO STREET CAPITAL MANAGEMENT, LP added 128,224 shares (+39.5%) to their portfolio in Q3 2025, for an estimated $402,623
PACIFIC RIDGE CAPITAL PARTNERS, LLC added 125,245 shares (+21.8%) to their portfolio in Q4 2025, for an estimated $498,475
MEROS INVESTMENT MANAGEMENT, LP added 74,749 shares (+75.3%) to their portfolio in Q3 2025, for an estimated $234,711
GSA CAPITAL PARTNERS LLP removed 71,696 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $225,125

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SRTS Analyst Ratings

Wall Street analysts have issued reports on $SRTS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

HC Wainwright & Co. issued a "Buy" rating on 08/12/2025

To track analyst ratings and price targets for SRTS, check out Quiver Quantitative's $SRTS forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $20,000 of SOUTHEASTERN COMMUNITY COLLEGE lobbying was just disclosed

1 week, 1 day ago | Feb. 6, 2026 12:03 a.m. UTC

$20,000 of SOUTHEASTERN COMMUNITY COLLEGE lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"None"

You can find more data on corporate lobbying on Quiver Quantitative.

EML Insider Trading Activity

EML insiders have traded $EML stock on the open market 25 times in the past 6 months. Of those trades, 25 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $EML stock by insiders over the last 6 months:

FREDERICK D. DISANTO has made 16 purchases buying 15,505 shares for an estimated $323,442 and 0 sales.
JAMES A MITAROTONDA has made 4 purchases buying 6,672 shares for an estimated $132,079 and 0 sales.
JOHN EVERETS purchased 1,435 shares for an estimated $28,054
MICHAEL J MARDY purchased 1,177 shares for an estimated $23,010
PEGGY SCOTT purchased 1,140 shares for an estimated $22,287
CHARLES W HENRY purchased 1,059 shares for an estimated $20,703
CHAN GALBATO purchased 1,029 shares for an estimated $20,116

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

EML Hedge Fund Activity

We have seen 39 institutional investors add shares of EML stock to their portfolio, and 26 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ROYAL BANK OF CANADA removed 22,120 shares (-98.2%) from their portfolio in Q3 2025, for an estimated $518,935
JANNEY MONTGOMERY SCOTT LLC removed 18,745 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $439,757
FIRST TRUST ADVISORS LP removed 18,455 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $432,954
GATEPASS CAPITAL, LLC added 15,800 shares (+87.8%) to their portfolio in Q3 2025, for an estimated $370,668
SEGALL BRYANT & HAMILL, LLC removed 12,680 shares (-43.2%) from their portfolio in Q3 2025, for an estimated $297,472
TETON ADVISORS, LLC removed 11,365 shares (-8.1%) from their portfolio in Q4 2025, for an estimated $223,776
JANE STREET GROUP, LLC added 10,389 shares (+inf%) to their portfolio in Q3 2025, for an estimated $243,725

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $30,000 of ONTO INNOVATION INC. lobbying was just disclosed

1 week, 1 day ago | Feb. 6, 2026 12:03 a.m. UTC

$30,000 of ONTO INNOVATION INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to trade, export controls and tariffs. Issues related to export controls"

You can find more data on corporate lobbying on Quiver Quantitative.

ONTO Hedge Fund Activity

We have seen 257 institutional investors add shares of ONTO stock to their portfolio, and 242 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WELLINGTON MANAGEMENT GROUP LLP added 1,292,772 shares (+1217.0%) to their portfolio in Q3 2025, for an estimated $167,051,997
BLACKROCK, INC. removed 1,272,021 shares (-19.6%) from their portfolio in Q3 2025, for an estimated $164,370,553
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 984,457 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $127,211,533
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 882,901 shares (+80.3%) to their portfolio in Q3 2025, for an estimated $114,088,467
VOYA INVESTMENT MANAGEMENT LLC added 849,702 shares (+4494.6%) to their portfolio in Q3 2025, for an estimated $109,798,492
QUBE RESEARCH & TECHNOLOGIES LTD removed 775,499 shares (-86.1%) from their portfolio in Q3 2025, for an estimated $100,209,980
RAFFERTY ASSET MANAGEMENT, LLC removed 639,566 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $82,644,718

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ONTO Analyst Ratings

Wall Street analysts have issued reports on $ONTO in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 01/20/2026
B. Riley Securities issued a "Buy" rating on 01/15/2026
Oppenheimer issued a "Outperform" rating on 10/14/2025
Jefferies issued a "Buy" rating on 09/23/2025

To track analyst ratings and price targets for ONTO, check out Quiver Quantitative's $ONTO forecast page.

ONTO Price Targets

Multiple analysts have issued price targets for $ONTO recently. We have seen 6 analysts offer price targets for $ONTO in the last 6 months, with a median target of $190.0.

Here are some recent targets:

Charles Shi from Needham set a target price of $260.0 on 01/20/2026
Craig Ellis from B. Riley Securities set a target price of $240.0 on 01/15/2026
Brian Chin from Stifel set a target price of $180.0 on 01/14/2026
Blayne Curtis from Jefferies set a target price of $200.0 on 12/15/2025
Mark Lipacis from Evercore ISI Group set a target price of $160.0 on 11/05/2025
Edward Yang from Oppenheimer set a target price of $180.0 on 10/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $11,000 of RAYONIER lobbying was just disclosed

1 week, 1 day ago | Feb. 5, 2026 9:02 p.m. UTC

$11,000 of RAYONIER lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Forestry Issues"

You can find more data on corporate lobbying on Quiver Quantitative.

RYN Insider Trading Activity

RYN insiders have traded $RYN stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $RYN stock by insiders over the last 6 months:

CHRISTOPHER T CORR (SVP, Real Estate Development) sold 14,255 shares for an estimated $301,065

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

RYN Hedge Fund Activity

We have seen 233 institutional investors add shares of RYN stock to their portfolio, and 152 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PRICE T ROWE ASSOCIATES INC /MD/ removed 6,630,256 shares (-39.2%) from their portfolio in Q3 2025, for an estimated $175,966,994
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ added 4,496,725 shares (+inf%) to their portfolio in Q3 2025, for an estimated $119,343,081
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 747,545 shares (-99.9%) from their portfolio in Q3 2025, for an estimated $19,839,844
GOTHAM ASSET MANAGEMENT, LLC added 683,517 shares (+246.6%) to their portfolio in Q3 2025, for an estimated $18,140,541
FULLER & THALER ASSET MANAGEMENT, INC. added 651,879 shares (+62.2%) to their portfolio in Q3 2025, for an estimated $17,300,868
VICTORY CAPITAL MANAGEMENT INC removed 533,572 shares (-18.0%) from their portfolio in Q3 2025, for an estimated $14,161,000
NUVEEN, LLC removed 507,763 shares (-61.7%) from their portfolio in Q3 2025, for an estimated $13,476,030

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

RYN Price Targets

Multiple analysts have issued price targets for $RYN recently. We have seen 2 analysts offer price targets for $RYN in the last 6 months, with a median target of $25.0.

Here are some recent targets:

Michael Roxland from Truist Securities set a target price of $26.0 on 01/06/2026
Anthony Pettinari from Citigroup set a target price of $24.0 on 11/12/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $150,000 of CORMEDIX INC. lobbying was just disclosed

1 week, 1 day ago | Feb. 5, 2026 9:02 p.m. UTC

$150,000 of CORMEDIX INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 2172/S. 1058, Preserving Patient Access to Home Infusion Act H.R. 6214/S. 2730, Kidney Care Access Protection Act"

You can find more data on corporate lobbying on Quiver Quantitative.

CRMD Insider Trading Activity

CRMD insiders have traded $CRMD stock on the open market 15 times in the past 6 months. Of those trades, 1 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $CRMD stock by insiders over the last 6 months:

JANET DILLIONE has made 0 purchases and 5 sales selling 147,000 shares for an estimated $1,547,555.
JOSEPH TODISCO (Chief Executive Officer) has made 0 purchases and 2 sales selling 80,000 shares for an estimated $1,010,000.
ELIZABETH HURLBURT (Chief Operating Officer) has made 0 purchases and 2 sales selling 53,997 shares for an estimated $711,817.
KAUFMAN BETH ZELNICK (Chief Legal Officer) has made 0 purchases and 2 sales selling 50,000 shares for an estimated $670,264.
STEVEN W LEFKOWITZ sold 40,000 shares for an estimated $475,200
ALAN W DUNTON has made 0 purchases and 2 sales selling 30,000 shares for an estimated $391,300.
MYRON KAPLAN purchased 25,000 shares for an estimated $275,500

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CRMD Hedge Fund Activity

We have seen 144 institutional investors add shares of CRMD stock to their portfolio, and 71 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

DEERFIELD MANAGEMENT COMPANY, L.P. added 3,323,833 shares (+inf%) to their portfolio in Q3 2025, for an estimated $38,656,177
MARSHALL WACE, LLP added 893,518 shares (+34.6%) to their portfolio in Q3 2025, for an estimated $10,391,614
JUMP FINANCIAL, LLC added 774,083 shares (+inf%) to their portfolio in Q3 2025, for an estimated $9,002,585
NUVEEN, LLC removed 772,997 shares (-52.6%) from their portfolio in Q3 2025, for an estimated $8,989,955
GHISALLO CAPITAL MANAGEMENT LLC removed 750,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $8,722,500
ANSON FUNDS MANAGEMENT LP removed 725,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $8,431,750
RAYMOND JAMES FINANCIAL INC added 564,688 shares (+646.8%) to their portfolio in Q3 2025, for an estimated $6,567,321

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CRMD Analyst Ratings

Wall Street analysts have issued reports on $CRMD in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

HC Wainwright & Co. issued a "Buy" rating on 01/23/2026
Needham issued a "Buy" rating on 01/08/2026
D. Boral Capital issued a "Buy" rating on 12/18/2025
RBC Capital issued a "Outperform" rating on 10/21/2025
JMP Securities issued a "Market Outperform" rating on 09/09/2025

To track analyst ratings and price targets for CRMD, check out Quiver Quantitative's $CRMD forecast page.

CRMD Price Targets

Multiple analysts have issued price targets for $CRMD recently. We have seen 5 analysts offer price targets for $CRMD in the last 6 months, with a median target of $14.0.

Here are some recent targets:

Brandon Folkes from HC Wainwright & Co. set a target price of $13.0 on 01/23/2026
Leonid Timashev from RBC Capital set a target price of $13.0 on 01/21/2026
Jason Kolbert from D. Boral Capital set a target price of $14.0 on 01/08/2026
Serge Belanger from Needham set a target price of $15.0 on 01/08/2026
Jason N. Butler from JMP Securities set a target price of $22.0 on 09/09/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $30,000 of MIMEDX lobbying was just disclosed

1 week, 1 day ago | Feb. 5, 2026 9:02 p.m. UTC

$30,000 of MIMEDX lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"regulatory issues related to the delivery of wound management and skin substitutes for Medicare patients"

You can find more data on corporate lobbying on Quiver Quantitative.

MDXG Insider Trading Activity

MDXG insiders have traded $MDXG stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MDXG stock by insiders over the last 6 months:

KIMBERLY MAERSK-MOLLER (Chief Commercial Officer) sold 58,300 shares for an estimated $432,329

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MDXG Hedge Fund Activity

We have seen 103 institutional investors add shares of MDXG stock to their portfolio, and 105 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FIRST LIGHT ASSET MANAGEMENT, LLC added 1,725,458 shares (+89.5%) to their portfolio in Q3 2025, for an estimated $12,043,696
NANTAHALA CAPITAL MANAGEMENT, LLC added 1,466,566 shares (+inf%) to their portfolio in Q3 2025, for an estimated $10,236,630
DISCIPLINED GROWTH INVESTORS INC /MN added 1,022,202 shares (+283.0%) to their portfolio in Q3 2025, for an estimated $7,134,969
TRIGRAN INVESTMENTS, INC. removed 689,430 shares (-8.2%) from their portfolio in Q3 2025, for an estimated $4,812,221
MILLENNIUM MANAGEMENT LLC removed 534,790 shares (-32.0%) from their portfolio in Q3 2025, for an estimated $3,732,834
AQR CAPITAL MANAGEMENT LLC added 510,017 shares (+1502.8%) to their portfolio in Q3 2025, for an estimated $3,559,918
GOLDMAN SACHS GROUP INC added 480,476 shares (+62.7%) to their portfolio in Q3 2025, for an estimated $3,353,722

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MDXG Analyst Ratings

Wall Street analysts have issued reports on $MDXG in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Mizuho issued a "Outperform" rating on 12/17/2025

To track analyst ratings and price targets for MDXG, check out Quiver Quantitative's $MDXG forecast page.

MDXG Price Targets

Multiple analysts have issued price targets for $MDXG recently. We have seen 2 analysts offer price targets for $MDXG in the last 6 months, with a median target of $10.0.

Here are some recent targets:

Brooks O'Neil from Lake Street set a target price of $10.0 on 01/20/2026
Anthony Petrone from Mizuho set a target price of $10.0 on 12/17/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $10,000 of TEXAS INSTRUMENTS INCORPORATED lobbying was just disclosed

1 week, 1 day ago | Feb. 5, 2026 9:02 p.m. UTC

$10,000 of TEXAS INSTRUMENTS INCORPORATED lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"None"

You can find more data on corporate lobbying on Quiver Quantitative.

TXN Congressional Stock Trading

Members of Congress have traded $TXN stock 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $TXN stock by members of Congress over the last 6 months:

REPRESENTATIVE JULIE JOHNSON has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 12/18, 11/13, 08/14.
REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 11/26.
REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 0 purchases and 3 sales worth up to $80,000 on 10/10.
SENATOR MARKWAYNE MULLIN sold up to $50,000 on 09/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

TXN Insider Trading Activity

TXN insiders have traded $TXN stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $TXN stock by insiders over the last 6 months:

RONALD KIRK sold 9,990 shares for an estimated $1,621,687
AHMAD BAHAI (Sr. Vice President) sold 1,500 shares for an estimated $308,030
CHRISTINE WITZSCHE (Sr. Vice President) sold 1,000 shares for an estimated $164,306

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TXN Hedge Fund Activity

We have seen 999 institutional investors add shares of TXN stock to their portfolio, and 1,223 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 5,774,791 shares (+53.9%) to their portfolio in Q3 2025, for an estimated $1,061,002,350
AMUNDI added 3,580,147 shares (+61.0%) to their portfolio in Q3 2025, for an estimated $657,780,408
CITADEL ADVISORS LLC removed 3,466,542 shares (-91.6%) from their portfolio in Q3 2025, for an estimated $636,907,761
SOUNDWATCH CAPITAL LLC removed 2,972,576 shares (-99.9%) from their portfolio in Q3 2025, for an estimated $546,151,388
JPMORGAN CHASE & CO removed 2,943,633 shares (-9.8%) from their portfolio in Q3 2025, for an estimated $540,833,691
INVESCO LTD. added 2,366,695 shares (+16.8%) to their portfolio in Q3 2025, for an estimated $434,832,872
WELLINGTON MANAGEMENT GROUP LLP removed 2,188,631 shares (-11.4%) from their portfolio in Q3 2025, for an estimated $402,117,173

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TXN Analyst Ratings

Wall Street analysts have issued reports on $TXN in the last several months. We have seen 6 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

JP Morgan issued a "Overweight" rating on 01/28/2026
Benchmark issued a "Buy" rating on 01/28/2026
Mizuho issued a "Underperform" rating on 01/28/2026
Rosenblatt issued a "Buy" rating on 01/28/2026
Susquehanna issued a "Positive" rating on 10/22/2025
Goldman Sachs issued a "Buy" rating on 10/22/2025
TD Cowen issued a "Buy" rating on 10/22/2025

To track analyst ratings and price targets for TXN, check out Quiver Quantitative's $TXN forecast page.

TXN Price Targets

Multiple analysts have issued price targets for $TXN recently. We have seen 18 analysts offer price targets for $TXN in the last 6 months, with a median target of $225.0.

Here are some recent targets:

Kevin Cassidy from Rosenblatt set a target price of $240.0 on 02/05/2026
Ross Seymore from Deutsche Bank set a target price of $205.0 on 01/28/2026
Cody Acree from Benchmark set a target price of $250.0 on 01/28/2026
Harlan Sur from JP Morgan set a target price of $227.0 on 01/28/2026
Blayne Curtis from Jefferies set a target price of $210.0 on 01/28/2026
James Schneider from Goldman Sachs set a target price of $175.0 on 01/28/2026
Timothy Arcuri from UBS set a target price of $260.0 on 01/28/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $15,000 of CAREDX lobbying was just disclosed

1 week, 2 days ago | Feb. 5, 2026 3:02 a.m. UTC

$15,000 of CAREDX lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"None"

You can find more data on corporate lobbying on Quiver Quantitative.

CDNA Insider Trading Activity

CDNA insiders have traded $CDNA stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $CDNA stock by insiders over the last 6 months:

JOHN WALTER JR HANNA (President and CEO) has made 0 purchases and 3 sales selling 29,636 shares for an estimated $626,026.
JEFFREY ADAM NOVACK (Secretary and General Counsel) has made 0 purchases and 4 sales selling 14,422 shares for an estimated $272,813.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CDNA Hedge Fund Activity

We have seen 94 institutional investors add shares of CDNA stock to their portfolio, and 111 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

INVESCO LTD. removed 2,433,674 shares (-95.7%) from their portfolio in Q3 2025, for an estimated $35,385,619
DEERFIELD MANAGEMENT COMPANY, L.P. added 2,191,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $31,857,139
BRAIDWELL LP added 2,182,781 shares (+inf%) to their portfolio in Q3 2025, for an estimated $31,737,635
HOOD RIVER CAPITAL MANAGEMENT LLC removed 1,765,981 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $25,677,363
NEXT CENTURY GROWTH INVESTORS LLC removed 1,125,454 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $16,364,101
BAMCO INC /NY/ added 719,523 shares (+29.5%) to their portfolio in Q3 2025, for an estimated $10,461,864
KENT LAKE PR LLC added 550,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $7,996,999

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CDNA Analyst Ratings

Wall Street analysts have issued reports on $CDNA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

BTIG issued a "Buy" rating on 11/06/2025

To track analyst ratings and price targets for CDNA, check out Quiver Quantitative's $CDNA forecast page.

CDNA Price Targets

Multiple analysts have issued price targets for $CDNA recently. We have seen 2 analysts offer price targets for $CDNA in the last 6 months, with a median target of $21.5.

Here are some recent targets:

Brandon Couillard from Wells Fargo set a target price of $18.0 on 12/15/2025
Mark Massaro from BTIG set a target price of $25.0 on 11/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $100,000 of AMERICAN DENTAL EDUCATION ASSOCIATION lobbying was just disclosed

1 week, 2 days ago | Feb. 5, 2026 12:02 a.m. UTC

$100,000 of AMERICAN DENTAL EDUCATION ASSOCIATION lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Oral health workforce and research funding, higher education Oral health education funding and policy Higher education policy & student loan policy"

You can find more data on corporate lobbying on Quiver Quantitative.

TAL Hedge Fund Activity

We have seen 118 institutional investors add shares of TAL stock to their portfolio, and 91 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ASPEX MANAGEMENT (HK) LTD removed 21,586,517 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $241,768,990
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 13,942,562 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $156,156,694
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND removed 7,197,100 shares (-63.5%) from their portfolio in Q3 2025, for an estimated $80,607,520
SERENITY CAPITAL MANAGEMENT PTE. LTD. added 4,701,422 shares (+16237.0%) to their portfolio in Q3 2025, for an estimated $52,655,926
KRANE FUNDS ADVISORS LLC added 4,684,426 shares (+25.5%) to their portfolio in Q3 2025, for an estimated $52,465,571
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 4,462,149 shares (+3989.3%) to their portfolio in Q3 2025, for an estimated $49,976,068
CAPITOLIS LIQUID GLOBAL MARKETS LLC added 4,277,500 shares (+153.7%) to their portfolio in Q3 2025, for an estimated $47,908,000

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $10,000 of BRINKS INC. lobbying was just disclosed

1 week, 3 days ago | Feb. 4, 2026 12:02 a.m. UTC

$10,000 of BRINKS INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"The Payment Choice Act of 2025 - Summary A bipartisan bill introduced in the Senate and House of Representatives. Its purpose is to ensure that businesses accept cash for on-site sales under $500 and cannot charge cash-paying customers a higher price than those using other payment methods. The bill allows for exceptions, such as a business providing a fee-free device to convert cash to a prepaid card. S. 2326 - Payment Choice Act of 2025 1119th Congress (2025-2026) - Introduced in Senate 07/17/2025 Sponsor: Sen. Cramer, Kevin [R-ND] Committees: Senate - Banking, Housing, Urban Affairs To ensure that United States currency is treated as legal tender to be accepted as payment for purchases of goods and services at brick-and-mortar businesses throughout the United States, and for other purposes. H.R.1138 - Payment Choice Act of 2025 119th Congress (2025-2026) - Introduced in House 02/07/2025 Sponsor: Rep. Rose, John W. [R=TN-6] Committees: House - Financial Affairs This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less and it prohibits them from charging cash-paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill establishes exceptions for this requirement, including by allowing a business to provide a device to provide prepaid cards on site for customers to use as payment. Among other requirements, such a card must not have a fee associated with its use and must not require a minimum payment of more than $1. The bill provides for enforcement through preventative relief, damages, and civil penalties. The Payment Choice Act of 2025 - Summary A bipartisan bill introduced in the Senate and House of Representatives. Its purpose is to ensure that businesses accept cash for on-site sales under $500 and cannot charge cash-paying customers a higher price than those using other payment methods. The bill allows for exceptions, such as a business providing a fee-free device to convert cash to a prepaid card. S. 2326 - Payment Choice Act of 2025 1119th Congress (2025-2026) - Introduced in Senate 07/17/2025 Sponsor: Sen. Cramer, Kevin [R-ND] Committees: Senate - Banking, Housing, Urban Affairs To ensure that United States currency is treated as legal tender to be accepted as payment for purchases of goods and services at brick-and-mortar businesses throughout the United States, and for other purposes. H.R.1138 - Payment Choice Act of 2025 119th Congress (2025-2026) - Introduced in House 02/07/2025 Sponsor: Rep. Rose, John W. [R=TN-6] Committees: House - Financial Affairs This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less and it prohibits them from charging cash-paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill establishes exceptions for this requirement, including by allowing a business to provide a device to provide prepaid cards on site for customers to use as payment. Among other requirements, such a card must not have a fee associated with its use and must not require a minimum payment of more than $1. The bill provides for enforcement through preventative relief, damages, and civil penalties. The Payment Choice Act of 2025 - Summary A bipartisan bill introduced in the Senate and House of Representatives. Its purpose is to ensure that businesses accept cash for on-site sales under $500 and cannot charge cash-paying customers a higher price than those using other payment methods. The bill allows for exceptions, such as a business providing a fee-free device to convert cash to a prepaid card. S. 2326 - Payment Choice Act of 2025 1119th Congress (2025-2026) - Introduced in Senate 07/17/2025 Sponsor: Sen. Cramer, Kevin [R-ND] Committees: Senate - Banking, Housing, Urban Affairs To ensure that United States currency is treated as legal tender to be accepted as payment for purchases of goods and services at brick-and-mortar businesses throughout the United States, and for other purposes. H.R.1138 - Payment Choice Act of 2025 119th Congress (2025-2026) - Introduced in House 02/07/2025 Sponsor: Rep. Rose, John W. [R=TN-6] Committees: House - Financial Affairs This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less and it prohibits them from charging cash-paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill establishes exceptions for this requirement, including by allowing a business to provide a device to provide prepaid cards on site for customers to use as payment. Among other requirements, such a card must not have a fee associated with its use and must not require a minimum payment of more than $1. The bill provides for enforcement through preventative relief, damages, and civil penalties."

You can find more data on corporate lobbying on Quiver Quantitative.

BCO Congressional Stock Trading

Members of Congress have traded $BCO stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $BCO stock by members of Congress over the last 6 months:

REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

BCO Insider Trading Activity

BCO insiders have traded $BCO stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $BCO stock by insiders over the last 6 months:

DANIEL J CASTILLO (EVP) has made 0 purchases and 2 sales selling 21,700 shares for an estimated $2,380,558.
MICHAEL E SWEENEY (Controller) has made 0 purchases and 7 sales selling 5,273 shares for an estimated $576,587.
ARTHELBERT LOUIS PARKER sold 540 shares for an estimated $62,100
KEITH R WYCHE sold 475 shares for an estimated $50,421

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BCO Hedge Fund Activity

We have seen 156 institutional investors add shares of BCO stock to their portfolio, and 161 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

AMERICAN CENTURY COMPANIES INC removed 442,803 shares (-26.8%) from their portfolio in Q3 2025, for an estimated $51,745,958
FMR LLC removed 372,007 shares (-7.2%) from their portfolio in Q3 2025, for an estimated $43,472,738
FOURTH SAIL CAPITAL LP removed 281,500 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $32,896,090
FIRST TRUST ADVISORS LP added 195,466 shares (+48.2%) to their portfolio in Q3 2025, for an estimated $22,842,156
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 193,114 shares (-9.8%) from their portfolio in Q3 2025, for an estimated $22,567,302
LSV ASSET MANAGEMENT added 175,773 shares (+16.3%) to their portfolio in Q3 2025, for an estimated $20,540,832
BARCLAYS PLC added 162,677 shares (+78.2%) to their portfolio in Q3 2025, for an estimated $19,010,434

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $10,000 of DIEBOLD NIXDORF lobbying was just disclosed

1 week, 3 days ago | Feb. 4, 2026 12:02 a.m. UTC

$10,000 of DIEBOLD NIXDORF lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"The Payment Choice Act of 2025 - Summary A bipartisan bill introduced in the Senate and House of Representatives. Its purpose is to ensure that businesses accept cash for on-site sales under $500 and cannot charge cash-paying customers a higher price than those using other payment methods. The bill allows for exceptions, such as a business providing a fee-free device to convert cash to a prepaid card. S. 2326 - Payment Choice Act of 2025 1119th Congress (2025-2026) - Introduced in Senate 07/17/2025 Sponsor: Sen. Cramer, Kevin [R-ND] Committees: Senate - Banking, Housing, Urban Affairs To ensure that United States currency is treated as legal tender to be accepted as payment for purchases of goods and services at brick-and-mortar businesses throughout the United States, and for other purposes. H.R.1138 - Payment Choice Act of 2025 119th Congress (2025-2026) - Introduced in House 02/07/2025 Sponsor: Rep. Rose, John W. [R=TN-6] Committees: House - Financial Affairs This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less and it prohibits them from charging cash-paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill establishes exceptions for this requirement, including by allowing a business to provide a device to provide prepaid cards on site for customers to use as payment. Among other requirements, such a card must not have a fee associated with its use and must not require a minimum payment of more than $1. The bill provides for enforcement through preventative relief, damages, and civil penalties. The Payment Choice Act of 2025 - Summary A bipartisan bill introduced in the Senate and House of Representatives. Its purpose is to ensure that businesses accept cash for on-site sales under $500 and cannot charge cash-paying customers a higher price than those using other payment methods. The bill allows for exceptions, such as a business providing a fee-free device to convert cash to a prepaid card. S. 2326 - Payment Choice Act of 2025 1119th Congress (2025-2026) - Introduced in Senate 07/17/2025 Sponsor: Sen. Cramer, Kevin [R-ND] Committees: Senate - Banking, Housing, Urban Affairs To ensure that United States currency is treated as legal tender to be accepted as payment for purchases of goods and services at brick-and-mortar businesses throughout the United States, and for other purposes. H.R.1138 - Payment Choice Act of 2025 119th Congress (2025-2026) - Introduced in House 02/07/2025 Sponsor: Rep. Rose, John W. [R=TN-6] Committees: House - Financial Affairs This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less and it prohibits them from charging cash-paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill establishes exceptions for this requirement, including by allowing a business to provide a device to provide prepaid cards on site for customers to use as payment. Among other requirements, such a card must not have a fee associated with its use and must not require a minimum payment of more than $1. The bill provides for enforcement through preventative relief, damages, and civil penalties. The Payment Choice Act of 2025 - Summary A bipartisan bill introduced in the Senate and House of Representatives. Its purpose is to ensure that businesses accept cash for on-site sales under $500 and cannot charge cash-paying customers a higher price than those using other payment methods. The bill allows for exceptions, such as a business providing a fee-free device to convert cash to a prepaid card. S. 2326 - Payment Choice Act of 2025 1119th Congress (2025-2026) - Introduced in Senate 07/17/2025 Sponsor: Sen. Cramer, Kevin [R-ND] Committees: Senate - Banking, Housing, Urban Affairs To ensure that United States currency is treated as legal tender to be accepted as payment for purchases of goods and services at brick-and-mortar businesses throughout the United States, and for other purposes. H.R.1138 - Payment Choice Act of 2025 119th Congress (2025-2026) - Introduced in House 02/07/2025 Sponsor: Rep. Rose, John W. [R=TN-6] Committees: House - Financial Affairs This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less and it prohibits them from charging cash-paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill establishes exceptions for this requirement, including by allowing a business to provide a device to provide prepaid cards on site for customers to use as payment. Among other requirements, such a card must not have a fee associated with its use and must not require a minimum payment of more than $1. The bill provides for enforcement through preventative relief, damages, and civil penalties."

You can find more data on corporate lobbying on Quiver Quantitative.

DBD Insider Trading Activity

DBD insiders have traded $DBD stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $DBD stock by insiders over the last 6 months:

CAPITAL MANAGEMENT LLC MILLSTREET has made 0 purchases and 5 sales selling 810,689 shares for an estimated $53,449,819.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DBD Hedge Fund Activity

We have seen 89 institutional investors add shares of DBD stock to their portfolio, and 62 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

HEIN PARK CAPITAL MANAGEMENT LP removed 868,339 shares (-68.5%) from their portfolio in Q3 2025, for an estimated $49,521,373
GLENDON CAPITAL MANAGEMENT LP removed 370,396 shares (-23.9%) from their portfolio in Q3 2025, for an estimated $21,123,683
ARENA CAPITAL ADVISORS, LLC- CA removed 366,530 shares (-37.5%) from their portfolio in Q3 2025, for an estimated $20,903,205
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 330,526 shares (+458.6%) to their portfolio in Q3 2025, for an estimated $18,849,897
MEDINA VALUE PARTNERS, LLC removed 318,919 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $18,187,950
BEACH POINT CAPITAL MANAGEMENT LP removed 213,753 shares (-13.6%) from their portfolio in Q3 2025, for an estimated $12,190,333
AMERICAN CENTURY COMPANIES INC added 212,790 shares (+73.6%) to their portfolio in Q3 2025, for an estimated $12,135,413

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

DBD Analyst Ratings

Wall Street analysts have issued reports on $DBD in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Wedbush issued a "Outperform" rating on 11/18/2025
DA Davidson issued a "Buy" rating on 08/19/2025

To track analyst ratings and price targets for DBD, check out Quiver Quantitative's $DBD forecast page.

DBD Price Targets

Multiple analysts have issued price targets for $DBD recently. We have seen 2 analysts offer price targets for $DBD in the last 6 months, with a median target of $80.0.

Here are some recent targets:

Antoine Legault from Wedbush set a target price of $80.0 on 11/18/2025
Matthew Summerville from DA Davidson set a target price of $80.0 on 08/19/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $30,000 of BROWNSTEIN HYATT FARBER AND SCHRECK ON BEHALF OF ROYAL CARIBBEAN CRUISES LTD lobbying was just disclosed

1 week, 3 days ago | Feb. 3, 2026 9:01 p.m. UTC

$30,000 of BROWNSTEIN HYATT FARBER AND SCHRECK ON BEHALF OF ROYAL CARIBBEAN CRUISES LTD lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"General issues related to cruise ship industry"

You can find more data on corporate lobbying on Quiver Quantitative.

RCL Congressional Stock Trading

Members of Congress have traded $RCL stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $RCL stock by members of Congress over the last 6 months:

REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 12/31.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

RCL Insider Trading Activity

RCL insiders have traded $RCL stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $RCL stock by insiders over the last 6 months:

RICHARD D FAIN has made 0 purchases and 3 sales selling 16,000 shares for an estimated $4,976,286.
VAGN O SORENSEN sold 10,300 shares for an estimated $3,399,412
MARITZA GOMEZ MONTIEL sold 1,100 shares for an estimated $309,936

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

RCL Hedge Fund Activity

We have seen 568 institutional investors add shares of RCL stock to their portfolio, and 553 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL RESEARCH GLOBAL INVESTORS removed 6,611,624 shares (-25.6%) from their portfolio in Q3 2025, for an estimated $2,139,389,293
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,540,491 shares (-99.4%) from their portfolio in Q3 2025, for an estimated $498,472,077
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 996,961 shares (-37.9%) from their portfolio in Q3 2025, for an estimated $322,596,640
GOLDMAN SACHS GROUP INC added 969,574 shares (+52.4%) to their portfolio in Q3 2025, for an estimated $313,734,754
BANK OF NEW YORK MELLON CORP removed 852,083 shares (-28.2%) from their portfolio in Q3 2025, for an estimated $275,717,017
CAPITAL WORLD INVESTORS removed 843,439 shares (-4.7%) from their portfolio in Q3 2025, for an estimated $272,919,991
PRICE T ROWE ASSOCIATES INC /MD/ added 751,170 shares (+85.9%) to their portfolio in Q3 2025, for an estimated $243,063,588

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

RCL Analyst Ratings

Wall Street analysts have issued reports on $RCL in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Wells Fargo issued a "Overweight" rating on 02/02/2026
Stifel issued a "Buy" rating on 01/30/2026
Barclays issued a "Overweight" rating on 01/30/2026
Goldman Sachs issued a "Buy" rating on 12/09/2025
UBS issued a "Buy" rating on 11/12/2025
Citigroup issued a "Buy" rating on 10/29/2025
Tigress Financial issued a "Buy" rating on 08/21/2025

To track analyst ratings and price targets for RCL, check out Quiver Quantitative's $RCL forecast page.

RCL Price Targets

Multiple analysts have issued price targets for $RCL recently. We have seen 13 analysts offer price targets for $RCL in the last 6 months, with a median target of $370.0.

Here are some recent targets:

Jamie Rollo from Morgan Stanley set a target price of $330.0 on 02/03/2026
Trey Bowers from Wells Fargo set a target price of $383.0 on 02/02/2026
Matthew Boss from JP Morgan set a target price of $371.0 on 02/02/2026
Lizzie Dove from Goldman Sachs set a target price of $370.0 on 02/02/2026
James Hardiman from Citigroup set a target price of $398.0 on 02/02/2026
Brandt Montour from Barclays set a target price of $361.0 on 01/30/2026
Steven Wieczynski from Stifel set a target price of $420.0 on 01/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $60,000 of PG&E lobbying was just disclosed

1 week, 4 days ago | Feb. 2, 2026 9:02 p.m. UTC

$60,000 of PG&E lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Energy and Utilites."

You can find more data on corporate lobbying on Quiver Quantitative.

PCG Congressional Stock Trading

Members of Congress have traded $PCG stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $PCG stock by members of Congress over the last 6 months:

REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

PCG Insider Trading Activity

PCG insiders have traded $PCG stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $PCG stock by insiders over the last 6 months:

JASON M GLICKMAN sold 29,473 shares for an estimated $470,094
JOHN O LARSEN purchased 7,500 shares for an estimated $119,700
III MARK E FERGUSON sold 7,000 shares for an estimated $106,050

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

PCG Hedge Fund Activity

We have seen 469 institutional investors add shares of PCG stock to their portfolio, and 345 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL RESEARCH GLOBAL INVESTORS added 31,613,248 shares (+84.7%) to their portfolio in Q3 2025, for an estimated $476,727,779
JPMORGAN CHASE & CO removed 23,960,148 shares (-41.5%) from their portfolio in Q3 2025, for an estimated $361,319,031
AQR CAPITAL MANAGEMENT LLC added 21,912,919 shares (+88.8%) to their portfolio in Q3 2025, for an estimated $330,446,818
CAPITAL INTERNATIONAL INVESTORS removed 12,884,953 shares (-26.6%) from their portfolio in Q3 2025, for an estimated $194,305,091
MILLENNIUM MANAGEMENT LLC removed 12,401,803 shares (-63.9%) from their portfolio in Q3 2025, for an estimated $187,019,189
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 12,049,345 shares (+70.1%) to their portfolio in Q3 2025, for an estimated $181,704,122
CITADEL ADVISORS LLC removed 9,950,954 shares (-65.3%) from their portfolio in Q3 2025, for an estimated $150,060,386

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PCG Analyst Ratings

Wall Street analysts have issued reports on $PCG in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Jefferies issued a "Buy" rating on 01/28/2026
Wells Fargo issued a "Overweight" rating on 01/20/2026
BMO Capital issued a "Outperform" rating on 10/14/2025
Barclays issued a "Overweight" rating on 10/01/2025

To track analyst ratings and price targets for PCG, check out Quiver Quantitative's $PCG forecast page.

PCG Price Targets

Multiple analysts have issued price targets for $PCG recently. We have seen 7 analysts offer price targets for $PCG in the last 6 months, with a median target of $21.0.

Here are some recent targets:

Julien Dumoulin-Smith from Jefferies set a target price of $20.0 on 01/28/2026
Shahriar Pourreza from Wells Fargo set a target price of $24.0 on 01/20/2026
Richard Sunderland from JP Morgan set a target price of $21.0 on 12/12/2025
Gregg Orrill from UBS set a target price of $18.0 on 10/24/2025
James Thalacker from BMO Capital set a target price of $25.0 on 10/14/2025
Nicholas Campanella from Barclays set a target price of $21.0 on 10/01/2025
David Arcaro from Morgan Stanley set a target price of $19.5 on 09/25/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $150,000 of SUN LIFE FINANCIAL (U.S.) SERVICES COMPANY INC. lobbying was just disclosed

2 weeks ago | Jan. 30, 2026 9:02 p.m. UTC

$150,000 of SUN LIFE FINANCIAL (U.S.) SERVICES COMPANY INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issue -- Medicaid Dental Benefits H.R.1 - One Big Beautiful Bill Act P.L.119-21 -- One Big Beautiful Bill Act S.2447 -- Repealing the Trump Sick Tax Act S.2084 -- Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2025 H.R.1397/S.1164 -- Increasing Access to Dental Insurance Act Issue -- ERISA E-Delivery for Health and Welfare Benefit Plans H.R.3758 -- Workers Disability Benefits Parity Act of 2025 Issue -- Medical Stop-Loss H.R.2571 -- Self-Insurance Protection Act S.2210 -- Unlocking Benefits for Independent Workers Act H.R.1320 -- To ensure that the provision of portable benefits to an individual is not considered in determining whether such individual is an employee of a person. H.R.6703 -- Lower Health Care Premiums for All Americans Act H.R.1521 -- Dental and Optometric Care Access (DOC Access) Act Issue -- Paid Family and Medical Leave Issue -- Rural Health Transformation Program S.2355/H.R.5582 -- Patients Deserve Price Tags Act H.R.5378 (118th) -- Lower Cost, More Transparency Act H.R.2547 -- Secure Family Futures Act H.R.1 -- One Big Beautiful Bill Act P.L.119-21 -- One Big Beautiful Bill Act P.L.117-169 -- Inflation Reduction Act H.R.996/S.400 -- Paid Family and Medical Leave Tax Credit Extension and Enhancement Act"

You can find more data on corporate lobbying on Quiver Quantitative.

SLF Hedge Fund Activity

We have seen 178 institutional investors add shares of SLF stock to their portfolio, and 200 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CIBC ASSET MANAGEMENT INC removed 2,098,682 shares (-38.0%) from their portfolio in Q3 2025, for an estimated $125,983,880
MACKENZIE FINANCIAL CORP removed 1,882,037 shares (-17.2%) from their portfolio in Q3 2025, for an estimated $112,978,681
BANK OF NOVA SCOTIA removed 1,443,539 shares (-23.4%) from their portfolio in Q3 2025, for an estimated $86,655,646
PICTON MAHONEY ASSET MANAGEMENT removed 1,322,756 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $79,405,042
ROYAL BANK OF CANADA removed 1,192,430 shares (-2.3%) from their portfolio in Q3 2025, for an estimated $71,581,572
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. removed 1,098,286 shares (-23.0%) from their portfolio in Q3 2025, for an estimated $65,930,108
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND added 1,005,000 shares (+251.3%) to their portfolio in Q3 2025, for an estimated $60,330,150

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SLF Analyst Ratings

Wall Street analysts have issued reports on $SLF in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

Barclays issued a "Underweight" rating on 10/08/2025
TD Securities issued a "Buy" rating on 10/08/2025

To track analyst ratings and price targets for SLF, check out Quiver Quantitative's $SLF forecast page.

SLF Price Targets

Multiple analysts have issued price targets for $SLF recently. We have seen 5 analysts offer price targets for $SLF in the last 6 months, with a median target of $87.0.

Here are some recent targets:

Darko Mihelic from RBC Capital set a target price of $84.0 on 11/10/2025
Mike Rizvanovic from Scotiabank set a target price of $87.0 on 11/07/2025
Paul Holden from CIBC set a target price of $94.0 on 10/30/2025
Alex Scott from Barclays set a target price of $84.0 on 10/08/2025
Mario Mendonca from TD Securities set a target price of $101.0 on 10/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $21,000 of ENCORE ENERGY CORP. lobbying was just disclosed

2 weeks ago | Jan. 30, 2026 9:02 p.m. UTC

$21,000 of ENCORE ENERGY CORP. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Uranium Mining 1872 Mining Law Russian and Chinese Uranium Imports for Nuclear Power Generation 1872 Mining Law Nuclear Fuel Production"

You can find more data on corporate lobbying on Quiver Quantitative.

EU Insider Trading Activity

EU insiders have traded $EU stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $EU stock by insiders over the last 6 months:

WILLIAM B. HARRIS sold 80,000 shares for an estimated $272,800
WILLIAM M SHERIFF (See Remarks) has made 0 purchases and 4 sales selling 74,500 shares for an estimated $188,510.
DENNIS STOVER has made 0 purchases and 2 sales selling 40,000 shares for an estimated $137,330.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

EU Hedge Fund Activity

We have seen 82 institutional investors add shares of EU stock to their portfolio, and 42 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

VAN ECK ASSOCIATES CORP added 6,933,454 shares (+76.7%) to their portfolio in Q3 2025, for an estimated $22,256,387
SEGRA CAPITAL MANAGEMENT, LLC removed 3,770,728 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $12,104,036
CITADEL ADVISORS LLC added 2,468,876 shares (+inf%) to their portfolio in Q3 2025, for an estimated $7,925,091
SUSQUEHANNA INTERNATIONAL GROUP, LLP added 1,970,831 shares (+326.2%) to their portfolio in Q3 2025, for an estimated $6,326,367
LLOYD HARBOR CAPITAL MANAGEMENT, LLC added 1,900,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $6,099,000
NOMURA HOLDINGS INC added 1,429,777 shares (+inf%) to their portfolio in Q3 2025, for an estimated $4,589,584
TWO SIGMA INVESTMENTS, LP added 1,185,050 shares (+inf%) to their portfolio in Q3 2025, for an estimated $3,804,010

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

EU Analyst Ratings

Wall Street analysts have issued reports on $EU in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

HC Wainwright & Co. issued a "Buy" rating on 08/12/2025

To track analyst ratings and price targets for EU, check out Quiver Quantitative's $EU forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $30,000 of QUANTA SERVICES INC. lobbying was just disclosed

2 weeks ago | Jan. 30, 2026 3:02 p.m. UTC

$30,000 of QUANTA SERVICES INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"General aerial firefighting issues with USFS. H.R. 471, Fix our Forests. S. 160, Aerial Firefighting Enhancement Act of 2025. General aerial firefighting issues with USFS. H.R. 471, Fix our Forests. S. 160, Aerial Firefighting Enhancement Act of 2025. General energy issues - electric power, pipeline, industrial and communications industries. Update on the status of disaster repairs (for T&D infrastructure and utilities) and report on mitigation efforts in hurricane impacted areas (Harvey, Maria and Fiona). H.R. 471, Fix our Forests Act. Standardizing Permitting and Expediting Economic Development (SPEED) Act (H.R. 4776) General energy issues for this specialty contractor with the largest highly trained skilled workforce in North America - electric power, pipeline, industrial and communications industries. Update on the status of disaster repairs (for T&D infrastructure and utilities) and report on mitigation efforts in hurricane impacted areas (Harvey, Maria and Fiona)."

You can find more data on corporate lobbying on Quiver Quantitative.

PWR Congressional Stock Trading

Members of Congress have traded $PWR stock 11 times in the past 6 months. Of those trades, 4 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $PWR stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 5 times. They made 3 purchases worth up to $45,000 on 11/18, 10/17, 09/12 and 2 sales worth up to $30,000 on 12/24, 12/19.
REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/02, 11/17.
REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

PWR Insider Trading Activity

PWR insiders have traded $PWR stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $PWR stock by insiders over the last 6 months:

DONALD WAYNE (EVP and General Counsel) has made 0 purchases and 5 sales selling 14,000 shares for an estimated $6,213,342.
GERALD A JR DUCEY (Pres. - Strategic Operations) sold 7,653 shares for an estimated $3,413,850
WORTHING JACKMAN sold 6,349 shares for an estimated $2,859,907
BERNARD FRIED sold 4,000 shares for an estimated $1,808,760

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

PWR Hedge Fund Activity

We have seen 730 institutional investors add shares of PWR stock to their portfolio, and 623 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 1,721,752 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $713,528,463
CAPITAL WORLD INVESTORS removed 1,585,509 shares (-18.9%) from their portfolio in Q3 2025, for an estimated $657,066,639
BANK OF AMERICA CORP /DE/ added 765,822 shares (+35.6%) to their portfolio in Q3 2025, for an estimated $317,371,953
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 718,261 shares (+54.7%) to their portfolio in Q3 2025, for an estimated $297,661,723
VOYA INVESTMENT MANAGEMENT LLC removed 593,968 shares (-83.5%) from their portfolio in Q3 2025, for an estimated $246,152,218
PRICE T ROWE ASSOCIATES INC /MD/ added 583,438 shares (+127.9%) to their portfolio in Q3 2025, for an estimated $241,788,375
JPMORGAN CHASE & CO removed 292,390 shares (-4.3%) from their portfolio in Q3 2025, for an estimated $121,172,263

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PWR Analyst Ratings

Wall Street analysts have issued reports on $PWR in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Jefferies issued a "Buy" rating on 11/03/2025
Citigroup issued a "Buy" rating on 10/31/2025
Stifel issued a "Buy" rating on 10/09/2025
Evercore ISI Group issued a "Outperform" rating on 08/08/2025

To track analyst ratings and price targets for PWR, check out Quiver Quantitative's $PWR forecast page.

PWR Price Targets

Multiple analysts have issued price targets for $PWR recently. We have seen 10 analysts offer price targets for $PWR in the last 6 months, with a median target of $516.0.

Here are some recent targets:

Andrew Kaplowitz from Citigroup set a target price of $540.0 on 01/26/2026
Brian Brophy from Stifel set a target price of $517.0 on 01/26/2026
Manish Somaiya from Cantor Fitzgerald set a target price of $520.0 on 01/23/2026
Chad Dillard from Bernstein set a target price of $428.0 on 12/19/2025
Mark Strouse from JP Morgan set a target price of $515.0 on 12/08/2025
Julien Dumoulin-Smith from Jefferies set a target price of $517.0 on 11/03/2025
Durgesh Chopra from Evercore ISI Group set a target price of $480.0 on 10/31/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $40,000 of DIVERSIFIED ENERGY COMPANY lobbying was just disclosed

2 weeks ago | Jan. 30, 2026 3:02 p.m. UTC

$40,000 of DIVERSIFIED ENERGY COMPANY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Monitor and discuss general issues surrounding conventional and unconventional natural gas and liquids production, marketing, transport and well retirement. Monitor and discuss general issues surrounding conventional and unconventional natural gas and liquids production, marketing, transport and well retirement."

You can find more data on corporate lobbying on Quiver Quantitative.

DEC Insider Trading Activity

DEC insiders have traded $DEC stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $DEC stock by insiders over the last 6 months:

RANDALL S. WADE sold 2,100,000 shares for an estimated $27,888,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DEC Hedge Fund Activity

We have seen 93 institutional investors add shares of DEC stock to their portfolio, and 59 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

AMERIPRISE FINANCIAL INC added 4,108,991 shares (+inf%) to their portfolio in Q3 2025, for an estimated $57,566,963
JUPITER ASSET MANAGEMENT LTD removed 2,926,886 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $41,005,672
ADAGE CAPITAL PARTNERS GP, L.L.C. added 1,000,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $14,010,000
VANGUARD GROUP INC removed 974,894 shares (-24.8%) from their portfolio in Q4 2025, for an estimated $14,116,465
ABERDEEN GROUP PLC added 959,988 shares (+inf%) to their portfolio in Q4 2025, for an estimated $13,900,626
CITADEL ADVISORS LLC added 767,378 shares (+47.6%) to their portfolio in Q3 2025, for an estimated $10,750,965
KOHLBERG KRAVIS ROBERTS & CO. L.P. removed 626,014 shares (-29.7%) from their portfolio in Q3 2025, for an estimated $8,770,456

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

DEC Analyst Ratings

Wall Street analysts have issued reports on $DEC in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Mizuho issued a "Outperform" rating on 12/12/2025
Clear Street issued a "Buy" rating on 11/25/2025
William Blair issued a "Outperform" rating on 11/18/2025
Citigroup issued a "Buy" rating on 11/13/2025

To track analyst ratings and price targets for DEC, check out Quiver Quantitative's $DEC forecast page.

DEC Price Targets

Multiple analysts have issued price targets for $DEC recently. We have seen 4 analysts offer price targets for $DEC in the last 6 months, with a median target of $24.0.

Here are some recent targets:

Nitin Kumar from Mizuho set a target price of $27.0 on 12/12/2025
Charles Meade from Johnson Rice set a target price of $23.0 on 12/05/2025
Tim Moore from Clear Street set a target price of $25.0 on 11/25/2025
Paul Diamond from Citigroup set a target price of $17.0 on 11/13/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $100,000 of NRG ENERGY INC lobbying was just disclosed

2 weeks, 1 day ago | Jan. 29, 2026 9:03 p.m. UTC

$100,000 of NRG ENERGY INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Permitting reform, co-location/data centers, and FCC Docket Number 25-110"

You can find more data on corporate lobbying on Quiver Quantitative.

NRG Insider Trading Activity

NRG insiders have traded $NRG stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $NRG stock by insiders over the last 6 months:

BRIAN CURCI (Exec VP & General Counsel) has made 0 purchases and 2 sales selling 107,556 shares for an estimated $17,258,059.
ROBERT J GAUDETTE (Exec VP, NRG Business) sold 45,000 shares for an estimated $7,144,200
VIRGINIA KINNEY (Exec VP, Chief Admin Officer) sold 20,000 shares for an estimated $3,276,400
BRUCE CHUNG (EVP & CFO) has made 0 purchases and 3 sales selling 20,000 shares for an estimated $3,148,134.
DAK LIYANEARACHCHI (Exec VP, Chief Technology Ofc.) sold 10,672 shares for an estimated $1,654,160

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NRG Hedge Fund Activity

We have seen 520 institutional investors add shares of NRG stock to their portfolio, and 507 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC added 5,202,627 shares (+54.9%) to their portfolio in Q3 2025, for an estimated $842,565,442
BANCO SANTANDER, S.A. removed 2,206,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $357,261,700
GOLDMAN SACHS GROUP INC removed 1,832,544 shares (-57.6%) from their portfolio in Q3 2025, for an estimated $296,780,500
JANE STREET GROUP, LLC removed 1,573,503 shares (-67.0%) from their portfolio in Q3 2025, for an estimated $254,828,810
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,332,394 shares (+85.8%) to their portfolio in Q3 2025, for an estimated $215,781,208
HOLOCENE ADVISORS, LP removed 1,149,645 shares (-79.6%) from their portfolio in Q3 2025, for an estimated $186,185,007
LSV ASSET MANAGEMENT removed 1,098,044 shares (-70.7%) from their portfolio in Q3 2025, for an estimated $177,828,225

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NRG Analyst Ratings

Wall Street analysts have issued reports on $NRG in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Jefferies issued a "Buy" rating on 01/27/2026
Wells Fargo issued a "Overweight" rating on 10/28/2025
Melius Research issued a "Buy" rating on 08/20/2025
Barclays issued a "Overweight" rating on 08/07/2025

To track analyst ratings and price targets for NRG, check out Quiver Quantitative's $NRG forecast page.

NRG Price Targets

Multiple analysts have issued price targets for $NRG recently. We have seen 9 analysts offer price targets for $NRG in the last 6 months, with a median target of $203.0.

Here are some recent targets:

Julien Dumoulin-Smith from Jefferies set a target price of $181.0 on 01/27/2026
Shahriar Pourreza from Wells Fargo set a target price of $206.0 on 01/20/2026
William Appicelli from UBS set a target price of $211.0 on 12/09/2025
James Thalacker from BMO Capital set a target price of $195.0 on 11/07/2025
Stephen Byrd from Morgan Stanley set a target price of $144.0 on 10/28/2025
Angie Storozynski from Seaport Global set a target price of $202.0 on 10/08/2025
Andrew Weisel from Scotiabank set a target price of $212.0 on 09/22/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $390,000 of NATIONAL FUEL GAS COMPANY lobbying was just disclosed

2 weeks, 1 day ago | Jan. 29, 2026 9:03 p.m. UTC

$390,000 of NATIONAL FUEL GAS COMPANY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"LIHEAP, pipeline permitting reform, climate change policy, pipeline safety reauthorization, energy policy (including renewable natural gas and hydrogen), energy choice, natural gas appliances , federal oversight of natural gas use, Energy Star program, pipeline security & cybersecurity, natural gas use in federal facilities, federal tax policy."

You can find more data on corporate lobbying on Quiver Quantitative.

NFG Hedge Fund Activity

We have seen 306 institutional investors add shares of NFG stock to their portfolio, and 255 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

AQR CAPITAL MANAGEMENT LLC added 1,087,067 shares (+103.4%) to their portfolio in Q3 2025, for an estimated $100,412,378
VICTORY CAPITAL MANAGEMENT INC removed 519,704 shares (-42.1%) from their portfolio in Q3 2025, for an estimated $48,005,058
WATERFORD ADVISORS, LLC removed 299,586 shares (-99.0%) from their portfolio in Q3 2025, for an estimated $27,672,758
YAUPON CAPITAL MANAGEMENT LP removed 294,684 shares (-62.3%) from their portfolio in Q3 2025, for an estimated $27,219,961
BLACKROCK, INC. added 257,158 shares (+3.0%) to their portfolio in Q3 2025, for an estimated $23,753,684
SQUAREPOINT OPS LLC added 250,130 shares (+428.8%) to their portfolio in Q3 2025, for an estimated $23,104,508
WESTWOOD HOLDINGS GROUP INC added 249,032 shares (+inf%) to their portfolio in Q3 2025, for an estimated $23,003,085

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $410,000 of THE MOSAIC COMPANY lobbying was just disclosed

2 weeks, 2 days ago | Jan. 28, 2026 12:02 p.m. UTC

$410,000 of THE MOSAIC COMPANY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Critical minerals PERMIT Act (HR3898); Maintaining Cooperative Permitting Act (S. 1014/HR3898) Legal trade remedies Federal tax code"

You can find more data on corporate lobbying on Quiver Quantitative.

MOS Congressional Stock Trading

Members of Congress have traded $MOS stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MOS stock by members of Congress over the last 6 months:

REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MOS Insider Trading Activity

MOS insiders have traded $MOS stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $MOS stock by insiders over the last 6 months:

JODY LYNNE KUZENKO purchased 685 shares for an estimated $17,488

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MOS Hedge Fund Activity

We have seen 358 institutional investors add shares of MOS stock to their portfolio, and 359 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC added 16,035,052 shares (+76.5%) to their portfolio in Q3 2025, for an estimated $556,095,603
AQR CAPITAL MANAGEMENT LLC added 7,294,205 shares (+632.6%) to their portfolio in Q3 2025, for an estimated $252,963,029
BOSTON PARTNERS removed 6,648,109 shares (-89.7%) from their portfolio in Q3 2025, for an estimated $230,556,420
BANK OF NEW YORK MELLON CORP added 3,894,947 shares (+102.3%) to their portfolio in Q3 2025, for an estimated $135,076,761
D. E. SHAW & CO., INC. removed 2,909,883 shares (-39.2%) from their portfolio in Q3 2025, for an estimated $100,914,742
FULLER & THALER ASSET MANAGEMENT, INC. removed 2,217,861 shares (-99.7%) from their portfolio in Q3 2025, for an estimated $76,915,419
MILLENNIUM MANAGEMENT LLC removed 1,895,347 shares (-76.1%) from their portfolio in Q3 2025, for an estimated $65,730,633

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MOS Analyst Ratings

Wall Street analysts have issued reports on $MOS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

UBS issued a "Buy" rating on 01/12/2026
Barclays issued a "Overweight" rating on 11/13/2025
JP Morgan issued a "Overweight" rating on 08/11/2025

To track analyst ratings and price targets for MOS, check out Quiver Quantitative's $MOS forecast page.

MOS Price Targets

Multiple analysts have issued price targets for $MOS recently. We have seen 13 analysts offer price targets for $MOS in the last 6 months, with a median target of $32.0.

Here are some recent targets:

Michael Sison from Wells Fargo set a target price of $27.0 on 01/23/2026
Andrew D. Wong from RBC Capital set a target price of $29.0 on 01/20/2026
Nigel Dally from Morgan Stanley set a target price of $35.0 on 01/14/2026
Lucas Beaumont from UBS set a target price of $33.0 on 01/12/2026
Christopher Parkinson from Mizuho set a target price of $28.0 on 12/18/2025
Benjamin Theurer from Barclays set a target price of $31.0 on 12/09/2025
Jeffrey Zekaukas from JP Morgan set a target price of $24.0 on 12/05/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $22,500 of 908 DEVICES INC. lobbying was just disclosed

2 weeks, 2 days ago | Jan. 28, 2026 12:02 p.m. UTC

$22,500 of 908 DEVICES INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"FY26 CJS Appropriations - Law Enforcement Funding FY26 DOD Appropriations - Air Force and Navy Funding Border Technology Funding Navy and Air Force Technology Funding Law Enforcement Funding"

You can find more data on corporate lobbying on Quiver Quantitative.

MASS Insider Trading Activity

MASS insiders have traded $MASS stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $MASS stock by insiders over the last 6 months:

JOSEPH H. IV GRIFFITH (Chief Financial Officer) has made 0 purchases and 3 sales selling 10,000 shares for an estimated $80,585.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MASS Hedge Fund Activity

We have seen 47 institutional investors add shares of MASS stock to their portfolio, and 52 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FIRST LIGHT ASSET MANAGEMENT, LLC added 1,442,883 shares (+135.2%) to their portfolio in Q3 2025, for an estimated $12,639,655
ARK INVESTMENT MANAGEMENT LLC removed 694,506 shares (-26.2%) from their portfolio in Q3 2025, for an estimated $6,083,872
GM ADVISORY GROUP, LLC removed 487,205 shares (-41.8%) from their portfolio in Q3 2025, for an estimated $4,267,915
FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 336,584 shares (+125.9%) to their portfolio in Q3 2025, for an estimated $2,948,475
MARSHALL WACE, LLP removed 209,157 shares (-32.2%) from their portfolio in Q3 2025, for an estimated $1,832,215
RAYMOND JAMES FINANCIAL INC added 176,616 shares (+2649.5%) to their portfolio in Q3 2025, for an estimated $1,547,156
D. E. SHAW & CO., INC. removed 160,612 shares (-86.3%) from their portfolio in Q3 2025, for an estimated $1,406,961

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MASS Analyst Ratings

Wall Street analysts have issued reports on $MASS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Leerink Partners issued a "Outperform" rating on 08/05/2025

To track analyst ratings and price targets for MASS, check out Quiver Quantitative's $MASS forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $52,500 of LIGHTBRIDGE CORPORATION lobbying was just disclosed

2 weeks, 3 days ago | Jan. 27, 2026 3:02 p.m. UTC

$52,500 of LIGHTBRIDGE CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Advocate for the adoption of Lightbridges technology for disposition of plutonium from weapons in nuclear power reactors and for the use of their fuel in nuclear powered icebreakers. Advocate for an amendment to the ADVANCE Act."

You can find more data on corporate lobbying on Quiver Quantitative.

LTBR Insider Trading Activity

LTBR insiders have traded $LTBR stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.

Here’s a breakdown of recent trading of $LTBR stock by insiders over the last 6 months:

SETH GRAE (President and CEO) has made 0 purchases and 3 sales selling 60,512 shares for an estimated $1,639,152.
ANDREY MUSHAKOV (EVP, Nuclear Operations) has made 0 purchases and 2 sales selling 42,691 shares for an estimated $981,494.
LARRY GOLDMAN (CFO) has made 0 purchases and 6 sales selling 51,211 shares for an estimated $886,560.
SWETA CHAKRABORTY has made 0 purchases and 6 sales selling 29,037 shares for an estimated $481,182.
JESSE L. FUNCHES has made 0 purchases and 2 sales selling 2,897 shares for an estimated $57,398.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

LTBR Hedge Fund Activity

We have seen 70 institutional investors add shares of LTBR stock to their portfolio, and 27 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

SUSQUEHANNA INTERNATIONAL GROUP, LLP added 578,530 shares (+2541.0%) to their portfolio in Q3 2025, for an estimated $12,270,621
AMERIPRISE FINANCIAL INC added 563,516 shares (+inf%) to their portfolio in Q3 2025, for an estimated $11,952,174
SCULPTOR CAPITAL LP removed 355,500 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $7,540,155
BLACKROCK, INC. added 346,047 shares (+30.2%) to their portfolio in Q3 2025, for an estimated $7,339,656
CITADEL ADVISORS LLC added 323,688 shares (+905.5%) to their portfolio in Q3 2025, for an estimated $6,865,422
BNP PARIBAS FINANCIAL MARKETS added 312,605 shares (+168.2%) to their portfolio in Q3 2025, for an estimated $6,630,352
AROSA CAPITAL MANAGEMENT LP removed 300,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $6,363,000

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $30,000 of BENTLEY SYSTEMS lobbying was just disclosed

2 weeks, 4 days ago | Jan. 26, 2026 9:03 p.m. UTC

$30,000 of BENTLEY SYSTEMS lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Surface transportation reauthorization and appropriations."

You can find more data on corporate lobbying on Quiver Quantitative.

BSY Insider Trading Activity

BSY insiders have traded $BSY stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $BSY stock by insiders over the last 6 months:

GREGORY S BENTLEY (Executive Chair & President) sold 37,160 shares for an estimated $2,037,575
THOMAS F TRIMBACK (Chief Accounting Officer) sold 560 shares for an estimated $24,091
DAVID R. SHAMAN (Chief Legal Officer) sold 400 shares for an estimated $23,700

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BSY Hedge Fund Activity

We have seen 238 institutional investors add shares of BSY stock to their portfolio, and 222 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 2,931,296 shares (+inf%) to their portfolio in Q3 2025, for an estimated $150,903,118
MANNING & NAPIER ADVISORS LLC added 2,347,598 shares (+inf%) to their portfolio in Q3 2025, for an estimated $120,854,345
VANGUARD GROUP INC added 1,792,591 shares (+10.7%) to their portfolio in Q3 2025, for an estimated $92,282,584
AXA S.A. removed 1,545,265 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $79,550,242
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 984,753 shares (+85.8%) to their portfolio in Q3 2025, for an estimated $50,695,084
PICTET ASSET MANAGEMENT HOLDING SA removed 658,823 shares (-17.8%) from their portfolio in Q3 2025, for an estimated $33,916,208
BESSEMER GROUP INC added 534,776 shares (+27.4%) to their portfolio in Q3 2025, for an estimated $27,530,268

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BSY Analyst Ratings

Wall Street analysts have issued reports on $BSY in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

BMO Capital issued a "Outperform" rating on 01/22/2026
Rosenblatt issued a "Buy" rating on 11/06/2025
Baird issued a "Outperform" rating on 11/06/2025
Piper Sandler issued a "Overweight" rating on 11/06/2025
Oppenheimer issued a "Outperform" rating on 08/07/2025
Goldman Sachs issued a "Sell" rating on 08/07/2025

To track analyst ratings and price targets for BSY, check out Quiver Quantitative's $BSY forecast page.

BSY Price Targets

Multiple analysts have issued price targets for $BSY recently. We have seen 10 analysts offer price targets for $BSY in the last 6 months, with a median target of $49.5.

Here are some recent targets:

Daniel Jester from BMO Capital set a target price of $48.0 on 01/22/2026
Kristen Owen from Oppenheimer set a target price of $53.0 on 01/20/2026
Clarke Jeffries from Piper Sandler set a target price of $45.0 on 01/13/2026
Guy Hardwick from Barclays set a target price of $47.0 on 01/12/2026
Matthew Hedberg from RBC Capital set a target price of $48.0 on 01/05/2026
Alexei Gogolev from JP Morgan set a target price of $51.0 on 11/06/2025
Blair Abernethy from Rosenblatt set a target price of $58.0 on 11/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $30,000 of ENVIRI CORPORATION (FORMERLY HARSCO CORPORATION) lobbying was just disclosed

2 weeks, 4 days ago | Jan. 26, 2026 9:03 p.m. UTC

$30,000 of ENVIRI CORPORATION (FORMERLY HARSCO CORPORATION) lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"IIJA reauthorization and appropriations"

You can find more data on corporate lobbying on Quiver Quantitative.

NVRI Insider Trading Activity

NVRI insiders have traded $NVRI stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $NVRI stock by insiders over the last 6 months:

JENNIFER OTT KOZAK (Senior Vice President & CHRO) sold 9,692 shares for an estimated $176,197

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NVRI Hedge Fund Activity

We have seen 92 institutional investors add shares of NVRI stock to their portfolio, and 92 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 4,561,968 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $57,891,373
PERTENTO PARTNERS LLP added 3,431,188 shares (+inf%) to their portfolio in Q3 2025, for an estimated $43,541,775
SHAY CAPITAL LLC added 1,940,000 shares (+2939.4%) to their portfolio in Q3 2025, for an estimated $24,618,600
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP added 1,683,800 shares (+inf%) to their portfolio in Q3 2025, for an estimated $21,367,422
MILLENNIUM MANAGEMENT LLC added 1,318,833 shares (+4621.0%) to their portfolio in Q3 2025, for an estimated $16,735,990
SCOPIA CAPITAL MANAGEMENT LP added 953,281 shares (+inf%) to their portfolio in Q3 2025, for an estimated $12,097,135
HG VORA CAPITAL MANAGEMENT, LLC removed 775,000 shares (-22.1%) from their portfolio in Q3 2025, for an estimated $9,834,750

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $200,000 of CENOVUS US CORPORATION (FKA CENOVUS ENERGY) lobbying was just disclosed

2 weeks, 6 days ago | Jan. 25, 2026 12:05 a.m. UTC

$200,000 of CENOVUS US CORPORATION (FKA CENOVUS ENERGY) lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Renewable Fuel Standard (RFS) issues relating to the Small Refinery Exemption program, RIN obligations, and Reid Vapor Pressure requirements Issues relating to EPA Refinery Risk Management Plan Issues related to H.R. 1435 / S. 2090 (Preserving Choice in Vehicle Purchases Act) and potential restrictions on consumer purchases of internal combustion engine vehicles Potential impacts of tariffs on energy imports; issues relating to trade"

You can find more data on corporate lobbying on Quiver Quantitative.

CVE Hedge Fund Activity

We have seen 185 institutional investors add shares of CVE stock to their portfolio, and 202 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL RESEARCH GLOBAL INVESTORS added 79,345,506 shares (+291.3%) to their portfolio in Q3 2025, for an estimated $1,348,080,146
CAPITAL WORLD INVESTORS removed 28,681,373 shares (-15.5%) from their portfolio in Q3 2025, for an estimated $487,296,527
FIL LTD added 27,283,176 shares (+11827.7%) to their portfolio in Q3 2025, for an estimated $463,541,160
MILLENNIUM MANAGEMENT LLC removed 20,792,158 shares (-88.1%) from their portfolio in Q3 2025, for an estimated $353,258,764
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 16,885,137 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $286,878,477
CAPITAL INTERNATIONAL INVESTORS removed 12,045,606 shares (-19.7%) from their portfolio in Q3 2025, for an estimated $204,654,845
CANADA PENSION PLAN INVESTMENT BOARD removed 10,731,438 shares (-69.1%) from their portfolio in Q3 2025, for an estimated $182,327,131

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CVE Analyst Ratings

Wall Street analysts have issued reports on $CVE in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

RBC Capital issued a "Outperform" rating on 11/17/2025
CIBC issued a "Outperformer" rating on 11/14/2025
TD Securities issued a "Buy" rating on 09/30/2025

To track analyst ratings and price targets for CVE, check out Quiver Quantitative's $CVE forecast page.

CVE Price Targets

Multiple analysts have issued price targets for $CVE recently. We have seen 5 analysts offer price targets for $CVE in the last 6 months, with a median target of $28.0.

Here are some recent targets:

Neil Mehta from Goldman Sachs set a target price of $20.0 on 01/02/2026
Greg Pardy from RBC Capital set a target price of $32.0 on 11/17/2025
Dennis Fong from CIBC set a target price of $32.0 on 11/14/2025
Menno Hulshof from TD Securities set a target price of $28.0 on 09/30/2025
Manav Gupta from UBS set a target price of $27.0 on 08/25/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $20,000 of NETGEAR lobbying was just disclosed

3 weeks ago | Jan. 24, 2026 12:48 a.m. UTC

$20,000 of NETGEAR lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Advocacy related to networking technology, cybersecurity requirements, data-protection standards, and manufacturing. Advocacy related to networking technology, cybersecurity requirements, data-protection standards, and manufacturing."

You can find more data on corporate lobbying on Quiver Quantitative.

NTGR Insider Trading Activity

NTGR insiders have traded $NTGR stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $NTGR stock by insiders over the last 6 months:

BRADLEY MAIORINO sold 13,063 shares for an estimated $460,601
SHRAVAN GOLI has made 0 purchases and 3 sales selling 13,804 shares for an estimated $368,230.
PRAMOD BADJATE (President & GM, NFB) sold 4,000 shares for an estimated $98,400
GRAEME MCLINDIN (VP, Mobile) has made 0 purchases and 2 sales selling 1,622 shares for an estimated $50,715.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NTGR Hedge Fund Activity

We have seen 99 institutional investors add shares of NTGR stock to their portfolio, and 97 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

LAZARD ASSET MANAGEMENT LLC added 256,266 shares (+87.6%) to their portfolio in Q3 2025, for an estimated $8,300,455
INVESCO LTD. removed 248,231 shares (-70.7%) from their portfolio in Q3 2025, for an estimated $8,040,202
JACOBS LEVY EQUITY MANAGEMENT, INC added 218,347 shares (+43.7%) to their portfolio in Q3 2025, for an estimated $7,072,259
CINCTIVE CAPITAL MANAGEMENT LP added 198,597 shares (+inf%) to their portfolio in Q3 2025, for an estimated $6,432,556
CITADEL ADVISORS LLC removed 196,742 shares (-84.1%) from their portfolio in Q3 2025, for an estimated $6,372,473
MILLENNIUM MANAGEMENT LLC removed 173,148 shares (-78.1%) from their portfolio in Q3 2025, for an estimated $5,608,263
PORTOLAN CAPITAL MANAGEMENT, LLC removed 169,294 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $5,483,432

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NTGR Analyst Ratings

Wall Street analysts have issued reports on $NTGR in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Raymond James issued a "Outperform" rating on 10/30/2025
Seaport Global issued a "Buy" rating on 10/01/2025

To track analyst ratings and price targets for NTGR, check out Quiver Quantitative's $NTGR forecast page.

NTGR Price Targets

Multiple analysts have issued price targets for $NTGR recently. We have seen 3 analysts offer price targets for $NTGR in the last 6 months, with a median target of $40.0.

Here are some recent targets:

Adam Tindle from Raymond James set a target price of $37.0 on 10/30/2025
Tore Svanberg from Stifel set a target price of $40.0 on 10/17/2025
Jay Goldberg from Seaport Global set a target price of $40.0 on 10/01/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $40,000 of 3D SYSTEMS CORPORATION lobbying was just disclosed

3 weeks ago | Jan. 24, 2026 12:48 a.m. UTC

$40,000 of 3D SYSTEMS CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Support Additive Manufacturing for defense and aerospace systems in the FY26 Continuing Resolution and FY 26 Defense Appropriations Act"

You can find more data on corporate lobbying on Quiver Quantitative.

DDD Hedge Fund Activity

We have seen 89 institutional investors add shares of DDD stock to their portfolio, and 78 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL WORLD INVESTORS added 5,208,333 shares (+inf%) to their portfolio in Q3 2025, for an estimated $15,104,165
MILLENNIUM MANAGEMENT LLC removed 3,088,172 shares (-97.9%) from their portfolio in Q3 2025, for an estimated $8,955,698
D. E. SHAW & CO., INC. added 2,483,561 shares (+353.2%) to their portfolio in Q3 2025, for an estimated $7,202,326
CITADEL ADVISORS LLC added 2,246,265 shares (+834.2%) to their portfolio in Q3 2025, for an estimated $6,514,168
GOLDMAN SACHS GROUP INC added 1,722,749 shares (+517.5%) to their portfolio in Q3 2025, for an estimated $4,995,972
UBS GROUP AG removed 1,435,942 shares (-55.4%) from their portfolio in Q3 2025, for an estimated $4,164,231
TWO SIGMA ADVISERS, LP added 1,258,800 shares (+114.3%) to their portfolio in Q3 2025, for an estimated $3,650,520

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $30,000 of PHIBRO ANIMAL HEALTH CORPORATION lobbying was just disclosed

3 weeks ago | Jan. 24, 2026 12:48 a.m. UTC

$30,000 of PHIBRO ANIMAL HEALTH CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Advocating for medicines to protect pigs from harmful diseases and lower the mortality rate of newborn pigs"

You can find more data on corporate lobbying on Quiver Quantitative.

PAHC Insider Trading Activity

PAHC insiders have traded $PAHC stock on the open market 50 times in the past 6 months. Of those trades, 0 have been purchases and 50 have been sales.

Here’s a breakdown of recent trading of $PAHC stock by insiders over the last 6 months:

JACK BENDHEIM (President and CEO) has made 0 purchases and 50 sales selling 267,800 shares for an estimated $11,327,351.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

PAHC Hedge Fund Activity

We have seen 120 institutional investors add shares of PAHC stock to their portfolio, and 97 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

EXODUSPOINT CAPITAL MANAGEMENT, LP removed 663,611 shares (-97.5%) from their portfolio in Q3 2025, for an estimated $26,849,701
FMR LLC added 537,958 shares (+902.7%) to their portfolio in Q3 2025, for an estimated $21,765,780
BRANDES INVESTMENT PARTNERS, LP removed 336,900 shares (-89.8%) from their portfolio in Q3 2025, for an estimated $13,630,974
MILLENNIUM MANAGEMENT LLC removed 271,310 shares (-94.8%) from their portfolio in Q3 2025, for an estimated $10,977,202
AMERICAN CENTURY COMPANIES INC removed 227,855 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $9,219,013
JPMORGAN CHASE & CO added 225,110 shares (+1730.9%) to their portfolio in Q3 2025, for an estimated $9,107,950
LORD, ABBETT & CO. LLC added 136,264 shares (+inf%) to their portfolio in Q3 2025, for an estimated $5,513,241

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PAHC Analyst Ratings

Wall Street analysts have issued reports on $PAHC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

JP Morgan issued a "Overweight" rating on 11/07/2025
B of A Securities issued a "Underperform" rating on 08/29/2025

To track analyst ratings and price targets for PAHC, check out Quiver Quantitative's $PAHC forecast page.

PAHC Price Targets

Multiple analysts have issued price targets for $PAHC recently. We have seen 2 analysts offer price targets for $PAHC in the last 6 months, with a median target of $38.5.

Here are some recent targets:

Ekaterina Knyazkova from JP Morgan set a target price of $50.0 on 11/07/2025
Derik De Bruin from B of A Securities set a target price of $27.0 on 08/29/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $60,000 of UNIVERSAL TECHNICAL INSTITUTE lobbying was just disclosed

3 weeks ago | Jan. 24, 2026 12:48 a.m. UTC

$60,000 of UNIVERSAL TECHNICAL INSTITUTE lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Advocate on issues related to higher education"

You can find more data on corporate lobbying on Quiver Quantitative.

UTI Insider Trading Activity

UTI insiders have traded $UTI stock on the open market 8 times in the past 6 months. Of those trades, 8 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $UTI stock by insiders over the last 6 months:

CAPITAL MANAGEMENT, LLC COLISEUM has made 6 purchases buying 1,255,173 shares for an estimated $30,813,450 and 0 sales.
ROBERT THOMAS DEVINCENZI has made 2 purchases buying 10,000 shares for an estimated $253,990 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

UTI Hedge Fund Activity

We have seen 124 institutional investors add shares of UTI stock to their portfolio, and 141 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC removed 1,052,250 shares (-77.3%) from their portfolio in Q3 2025, for an estimated $34,250,737
LORD, ABBETT & CO. LLC removed 948,967 shares (-46.7%) from their portfolio in Q3 2025, for an estimated $30,888,875
PRICE T ROWE ASSOCIATES INC /MD/ added 931,489 shares (+2519.2%) to their portfolio in Q3 2025, for an estimated $30,319,966
PERRITT CAPITAL MANAGEMENT INC removed 902,386 shares (-97.2%) from their portfolio in Q3 2025, for an estimated $29,372,664
THRIVENT FINANCIAL FOR LUTHERANS added 857,889 shares (+inf%) to their portfolio in Q3 2025, for an estimated $27,924,286
ROCKEFELLER CAPITAL MANAGEMENT L.P. added 736,168 shares (+inf%) to their portfolio in Q3 2025, for an estimated $23,962,268
BLACKROCK, INC. added 719,979 shares (+22.0%) to their portfolio in Q3 2025, for an estimated $23,435,316

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

UTI Analyst Ratings

Wall Street analysts have issued reports on $UTI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Barrington Research issued a "Outperform" rating on 01/21/2026
Rosenblatt issued a "Buy" rating on 11/20/2025

To track analyst ratings and price targets for UTI, check out Quiver Quantitative's $UTI forecast page.

UTI Price Targets

Multiple analysts have issued price targets for $UTI recently. We have seen 2 analysts offer price targets for $UTI in the last 6 months, with a median target of $36.0.

Here are some recent targets:

Alexander Paris from Barrington Research set a target price of $36.0 on 01/21/2026
Steve Frankel from Rosenblatt set a target price of $36.0 on 11/20/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $2,810,000 of PFIZER INC. lobbying was just disclosed

3 weeks ago | Jan. 24, 2026 12:48 a.m. UTC

$2,810,000 of PFIZER INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Vaccine Policy, Coverage and Access HR 4317 - PMB Reform Act of 2025 Gavi Vaccines Alliance Issues HR 2214 - DRUG Act S 832 - EPIC Act of 2025 S 864 - HELP Copays ACT S 882 - Patients Before Middlemen Act Prescription Drug-Use-Related Software (PDURS): Digital Medicine Lyme Disease Issues Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients IRA Biosimilars Pause Fix, Biosimilar Legislation H.R. 5256 - 340B Access ACT Inflation Reduction Act (IRA): Orphan Drug Exemption, Pill Penalty, Biosimilar Pause Vaccine Coverage and Access Drug Pricing Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients PBM Reform S 1702 - Access to Prescription Digital Therapeutics Act of 2025 Digital Therapeutics International Supply Chain Global Access Most Favored Nation Policies Tariffs Non-Tariff Trade Barriers United States-Mexico-Canada Agreement (USMCA)"

You can find more data on corporate lobbying on Quiver Quantitative.

PFE Congressional Stock Trading

Members of Congress have traded $PFE stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 11/18 and 2 sales worth up to $30,000 on 12/19, 08/05.
REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 08/04.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

PFE Hedge Fund Activity

We have seen 1,276 institutional investors add shares of PFE stock to their portfolio, and 1,389 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 24,513,278 shares (+55.9%) to their portfolio in Q3 2025, for an estimated $624,598,323
WELLINGTON MANAGEMENT GROUP LLP removed 16,541,586 shares (-21.5%) from their portfolio in Q3 2025, for an estimated $421,479,611
MILLENNIUM MANAGEMENT LLC removed 12,237,392 shares (-87.4%) from their portfolio in Q3 2025, for an estimated $311,808,748
BNP PARIBAS FINANCIAL MARKETS removed 11,413,258 shares (-54.2%) from their portfolio in Q3 2025, for an estimated $290,809,813
ROYAL BANK OF CANADA added 9,722,744 shares (+33.0%) to their portfolio in Q3 2025, for an estimated $247,735,517
THORNBURG INVESTMENT MANAGEMENT INC removed 9,009,301 shares (-86.1%) from their portfolio in Q3 2025, for an estimated $229,556,989
STARBOARD VALUE LP removed 8,542,149 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $217,653,956

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PFE Analyst Ratings

Wall Street analysts have issued reports on $PFE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Guggenheim issued a "Buy" rating on 11/24/2025

To track analyst ratings and price targets for PFE, check out Quiver Quantitative's $PFE forecast page.

PFE Price Targets

Multiple analysts have issued price targets for $PFE recently. We have seen 7 analysts offer price targets for $PFE in the last 6 months, with a median target of $27.0.

Here are some recent targets:

Michael Yee from UBS set a target price of $25.0 on 01/07/2026
Terence Flynn from Morgan Stanley set a target price of $27.0 on 12/17/2025
Jason Gerberry from B of A Securities set a target price of $28.0 on 12/15/2025
Geoff Meacham from Citigroup set a target price of $26.0 on 12/02/2025
Vamil Divan from Guggenheim set a target price of $35.0 on 11/24/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $330,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed

3 weeks ago | Jan. 23, 2026 9:48 p.m. UTC

$330,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act"

You can find more data on corporate lobbying on Quiver Quantitative.

HIMS Congressional Stock Trading

Members of Congress have traded $HIMS stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $HIMS stock by members of Congress over the last 6 months:

REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 08/04.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

HIMS Insider Trading Activity

HIMS insiders have traded $HIMS stock on the open market 53 times in the past 6 months. Of those trades, 0 have been purchases and 53 have been sales.

Here’s a breakdown of recent trading of $HIMS stock by insiders over the last 6 months:

ANDREW DUDUM (Chief Executive Officer) has made 0 purchases and 17 sales selling 1,076,432 shares for an estimated $53,976,385.
OLUYEMI OKUPE (Chief Financial Officer) has made 0 purchases and 12 sales selling 364,347 shares for an estimated $19,158,373.
PATRICK HARRISON CARROLL (Chief Medical Officer) has made 0 purchases and 3 sales selling 80,042 shares for an estimated $4,088,809.
MICHAEL CHI (Chief Operating Officer) has made 0 purchases and 8 sales selling 61,499 shares for an estimated $3,398,164.
SOLEIL BOUGHTON (Chief Legal Officer) has made 0 purchases and 9 sales selling 23,531 shares for an estimated $1,166,808.
IRENE BECKLUND (PAO) has made 0 purchases and 2 sales selling 16,821 shares for an estimated $733,472.
DEBORAH M. AUTOR (Chief Policy Officer) sold 7,054 shares for an estimated $258,952
GARCIA ANDREA G PEREZ sold 2,500 shares for an estimated $97,925

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

HIMS Hedge Fund Activity

We have seen 294 institutional investors add shares of HIMS stock to their portfolio, and 255 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 15,045,710 shares (+549.0%) to their portfolio in Q3 2025, for an estimated $853,392,671
SRS INVESTMENT MANAGEMENT, LLC removed 4,000,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $226,880,000
TIDAL INVESTMENTS LLC added 2,707,111 shares (+1779.6%) to their portfolio in Q3 2025, for an estimated $153,547,335
FARALLON CAPITAL MANAGEMENT LLC added 2,533,271 shares (+30.8%) to their portfolio in Q3 2025, for an estimated $143,687,131
PRICE T ROWE ASSOCIATES INC /MD/ added 2,504,252 shares (+444.1%) to their portfolio in Q3 2025, for an estimated $142,041,173
RENAISSANCE TECHNOLOGIES LLC added 2,227,400 shares (+32.4%) to their portfolio in Q3 2025, for an estimated $126,338,128
D. E. SHAW & CO., INC. removed 1,886,971 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $107,028,995

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

HIMS Analyst Ratings

Wall Street analysts have issued reports on $HIMS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

BTIG issued a "Buy" rating on 11/04/2025
B of A Securities issued a "Underperform" rating on 11/04/2025
Canaccord Genuity issued a "Buy" rating on 09/12/2025

To track analyst ratings and price targets for HIMS, check out Quiver Quantitative's $HIMS forecast page.

HIMS Price Targets

Multiple analysts have issued price targets for $HIMS recently. We have seen 6 analysts offer price targets for $HIMS in the last 6 months, with a median target of $42.5.

Here are some recent targets:

Mark Mahaney from Evercore ISI Group set a target price of $33.0 on 01/12/2026
Glen Santangelo from Barclays set a target price of $48.0 on 12/09/2025
David Larsen from BTIG set a target price of $85.0 on 11/04/2025
Allen Lutz from B of A Securities set a target price of $32.0 on 11/04/2025
Maria Ripps from Canaccord Genuity set a target price of $68.0 on 09/12/2025
Jailendra Singh from Truist Securities set a target price of $37.0 on 08/18/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $80,000 of VERTEX ENERGY OPERATING LLC lobbying was just disclosed

3 weeks ago | Jan. 23, 2026 9:48 p.m. UTC

$80,000 of VERTEX ENERGY OPERATING LLC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Advocate on issues related to energy and energy services. Advocate on issues related to energy and energy services."

You can find more data on corporate lobbying on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $15,000 of MORNINGSTAR DBRS INC. lobbying was just disclosed

3 weeks ago | Jan. 23, 2026 9:48 p.m. UTC

$15,000 of MORNINGSTAR DBRS INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to competition in the credit rating industry."

You can find more data on corporate lobbying on Quiver Quantitative.

MORN Congressional Stock Trading

Members of Congress have traded $MORN stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MORN stock by members of Congress over the last 6 months:

REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 08/04.
REPRESENTATIVE APRIL MCCLAIN DELANEY purchased up to $50,000 on 08/02.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MORN Insider Trading Activity

MORN insiders have traded $MORN stock on the open market 107 times in the past 6 months. Of those trades, 0 have been purchases and 107 have been sales.

Here’s a breakdown of recent trading of $MORN stock by insiders over the last 6 months:

JOSEPH D MANSUETO (Executive Chairman) has made 0 purchases and 106 sales selling 200,000 shares for an estimated $47,340,031.
CAROLINE J TSAY sold 600 shares for an estimated $131,090

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MORN Hedge Fund Activity

We have seen 239 institutional investors add shares of MORN stock to their portfolio, and 246 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

SELECT EQUITY GROUP, L.P. added 990,401 shares (+89.0%) to their portfolio in Q3 2025, for an estimated $229,782,936
BANK OF AMERICA CORP /DE/ removed 752,469 shares (-82.5%) from their portfolio in Q3 2025, for an estimated $174,580,332
MILLENNIUM MANAGEMENT LLC removed 512,417 shares (-63.2%) from their portfolio in Q3 2025, for an estimated $118,885,868
AQR CAPITAL MANAGEMENT LLC added 314,275 shares (+106.9%) to their portfolio in Q3 2025, for an estimated $72,914,942
GOLDMAN SACHS GROUP INC removed 279,027 shares (-73.9%) from their portfolio in Q3 2025, for an estimated $64,737,054
WASATCH ADVISORS LP removed 272,916 shares (-42.3%) from their portfolio in Q3 2025, for an estimated $63,319,241
RENAISSANCE TECHNOLOGIES LLC added 195,600 shares (+73.8%) to their portfolio in Q3 2025, for an estimated $45,381,156

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MORN Analyst Ratings

Wall Street analysts have issued reports on $MORN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

UBS issued a "Buy" rating on 10/30/2025

To track analyst ratings and price targets for MORN, check out Quiver Quantitative's $MORN forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $50,000 of INTUIT INC. AND AFFILIATES (FORMERLY INTUIT INC.) lobbying was just disclosed

3 weeks ago | Jan. 23, 2026 6:48 p.m. UTC

$50,000 of INTUIT INC. AND AFFILIATES (FORMERLY INTUIT INC.) lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Promote small business development and growth Support small business regulatory modernization Expanding access to capital Promote financial health and literacy for small businesses and consumers. Support greater access to financial services and financial inclusion. Promote payments infrastructure modernization and market competition, HR 915."

You can find more data on corporate lobbying on Quiver Quantitative.

INTU Congressional Stock Trading

Members of Congress have traded $INTU stock 6 times in the past 6 months. Of those trades, 5 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $INTU stock by members of Congress over the last 6 months:

SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 2 purchases worth up to $100,000 on 12/29, 09/24 and 0 sales.
REPRESENTATIVE JULIA LETLOW purchased up to $15,000 on 10/01.
REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 08/13 and 1 sale worth up to $15,000 on 09/11.
SENATOR JOHN W. HICKENLOOPER purchased up to $250,000 on 09/02.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

INTU Insider Trading Activity

INTU insiders have traded $INTU stock on the open market 118 times in the past 6 months. Of those trades, 0 have been purchases and 118 have been sales.

Here’s a breakdown of recent trading of $INTU stock by insiders over the last 6 months:

SCOTT D COOK has made 0 purchases and 100 sales selling 494,894 shares for an estimated $327,893,677.
SASAN K GOODARZI (CEO, President and Director) has made 0 purchases and 2 sales selling 41,000 shares for an estimated $26,653,960.
SANDEEP AUJLA (EVP and CFO) has made 0 purchases and 5 sales selling 3,644 shares for an estimated $2,401,358.
RICHARD L DALZELL has made 0 purchases and 11 sales selling 1,998 shares for an estimated $1,321,068.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

INTU Hedge Fund Activity

We have seen 1,118 institutional investors add shares of INTU stock to their portfolio, and 942 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,338,608 shares (+100.1%) to their portfolio in Q3 2025, for an estimated $2,279,968,789
PRICE T ROWE ASSOCIATES INC /MD/ removed 1,916,133 shares (-23.3%) from their portfolio in Q3 2025, for an estimated $1,308,546,387
WELLINGTON MANAGEMENT GROUP LLP removed 1,828,083 shares (-31.2%) from their portfolio in Q3 2025, for an estimated $1,248,416,161
JPMORGAN CHASE & CO added 1,748,269 shares (+19.8%) to their portfolio in Q3 2025, for an estimated $1,193,910,382
BLACKROCK, INC. added 1,672,758 shares (+6.5%) to their portfolio in Q3 2025, for an estimated $1,142,343,165
ALLIANCEBERNSTEIN L.P. added 1,295,199 shares (+183.8%) to their portfolio in Q3 2025, for an estimated $884,504,349
PARNASSUS INVESTMENTS, LLC removed 1,134,238 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $774,582,472

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

INTU Analyst Ratings

Wall Street analysts have issued reports on $INTU in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

TD Cowen issued a "Buy" rating on 01/08/2026
BMO Capital issued a "Outperform" rating on 11/21/2025
Wells Fargo issued a "Overweight" rating on 11/21/2025
RBC Capital issued a "Outperform" rating on 11/21/2025
Evercore ISI Group issued a "Outperform" rating on 11/18/2025
Keybanc issued a "Overweight" rating on 08/22/2025
Citigroup issued a "Buy" rating on 08/22/2025

To track analyst ratings and price targets for INTU, check out Quiver Quantitative's $INTU forecast page.

INTU Price Targets

Multiple analysts have issued price targets for $INTU recently. We have seen 15 analysts offer price targets for $INTU in the last 6 months, with a median target of $802.0.

Here are some recent targets:

Jared Levine from TD Cowen set a target price of $802.0 on 01/08/2026
Michael Turrin from Wells Fargo set a target price of $700.0 on 01/08/2026
Arvind Ramnani from Truist Securities set a target price of $739.0 on 01/06/2026
Rishi Jaluria from RBC Capital set a target price of $850.0 on 11/21/2025
Daniel Jester from BMO Capital set a target price of $810.0 on 11/21/2025
Kirk Materne from Evercore ISI Group set a target price of $875.0 on 11/18/2025
Steven Enders from Citigroup set a target price of $803.0 on 08/22/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $30,000 of ACADIA HEALTHCARE COMPANY INC. lobbying was just disclosed

3 weeks ago | Jan. 23, 2026 6:48 p.m. UTC

$30,000 of ACADIA HEALTHCARE COMPANY INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to healthcare, behavioral health, and regulatory framework."

You can find more data on corporate lobbying on Quiver Quantitative.

ACHC Hedge Fund Activity

We have seen 137 institutional investors add shares of ACHC stock to their portfolio, and 166 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ENGINE CAPITAL MANAGEMENT, LP added 2,585,574 shares (+inf%) to their portfolio in Q3 2025, for an estimated $64,018,812
KHROM CAPITAL MANAGEMENT LLC added 2,556,469 shares (+103.0%) to their portfolio in Q3 2025, for an estimated $63,298,172
BLACKROCK, INC. added 1,864,967 shares (+20.4%) to their portfolio in Q3 2025, for an estimated $46,176,582
GW&K INVESTMENT MANAGEMENT, LLC removed 1,349,272 shares (-85.4%) from their portfolio in Q3 2025, for an estimated $33,407,974
DEERFIELD MANAGEMENT COMPANY, L.P. added 1,189,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $29,439,640
RUBRIC CAPITAL MANAGEMENT LP added 1,100,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $27,236,000
WELLINGTON MANAGEMENT GROUP LLP added 993,205 shares (+11.8%) to their portfolio in Q3 2025, for an estimated $24,591,755

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ACHC Analyst Ratings

Wall Street analysts have issued reports on $ACHC in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Keybanc issued a "Overweight" rating on 11/18/2025
RBC Capital issued a "Outperform" rating on 11/12/2025
Guggenheim issued a "Buy" rating on 11/10/2025
UBS issued a "Buy" rating on 11/07/2025
Raymond James issued a "Outperform" rating on 10/03/2025

To track analyst ratings and price targets for ACHC, check out Quiver Quantitative's $ACHC forecast page.

ACHC Price Targets

Multiple analysts have issued price targets for $ACHC recently. We have seen 14 analysts offer price targets for $ACHC in the last 6 months, with a median target of $18.5.

Here are some recent targets:

Brian Tanquilut from Jefferies set a target price of $15.0 on 01/22/2026
Ryan Langston from TD Cowen set a target price of $22.0 on 01/16/2026
Ben Hendrix from RBC Capital set a target price of $17.0 on 01/14/2026
Ann Hynes from Mizuho set a target price of $17.0 on 12/18/2025
Andrew Mok from Barclays set a target price of $14.0 on 12/04/2025
Whit Mayo from Leerink Partners set a target price of $14.0 on 12/03/2025
Matthew Gillmor from Keybanc set a target price of $25.0 on 12/03/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $420,000 of EXACT SCIENCES lobbying was just disclosed

3 weeks, 1 day ago | Jan. 23, 2026 3:59 a.m. UTC

$420,000 of EXACT SCIENCES lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. Support colorectal cancer screening standards Support patient access to cancer screening and diagnostics. Support HR 1780/S 642 Finn Sawyer Access to Cancer Testing Act Support S 1410 Find It Early Act Support HR 2921/S 2745 Federal Firefighter Cancer Detection and Prevention Act of 2025 Support HR 1610 FIRE Cancer Act Support HR 4752/S 2760 Reducing Hereditary Cancer Act Support HR 7714 Colorectal Cancer Early Detection Act Support S 1717 Ensuring Patient Access to Critical Breakthrough Products Act Support veteran access to guideline-recommended colorectal cancer screening."

You can find more data on corporate lobbying on Quiver Quantitative.

EXAS Insider Trading Activity

EXAS insiders have traded $EXAS stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $EXAS stock by insiders over the last 6 months:

KATHERINE S ZANOTTI sold 12,000 shares for an estimated $780,000
JACOB A ORVILLE (EVP, GM, Screening) sold 5,000 shares for an estimated $375,000
JAMES HERRIOTT (SVP, General Counsel & Sec) has made 0 purchases and 3 sales selling 4,000 shares for an estimated $265,120.
BRIAN BARANICK (EVP, GM, Precision Oncology) sold 2,858 shares for an estimated $200,288
JAMES EDWARD DOYLE has made 0 purchases and 2 sales selling 3,485 shares for an estimated $182,399.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

EXAS Hedge Fund Activity

We have seen 291 institutional investors add shares of EXAS stock to their portfolio, and 257 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC removed 8,241,935 shares (-30.6%) from their portfolio in Q3 2025, for an estimated $450,916,263
WELLINGTON MANAGEMENT GROUP LLP removed 6,677,809 shares (-55.6%) from their portfolio in Q3 2025, for an estimated $365,342,930
CITADEL ADVISORS LLC added 3,506,084 shares (+805.1%) to their portfolio in Q3 2025, for an estimated $191,817,855
CANADA PENSION PLAN INVESTMENT BOARD added 2,500,056 shares (+2439.1%) to their portfolio in Q3 2025, for an estimated $136,778,063
AMERIPRISE FINANCIAL INC added 2,270,039 shares (+102.1%) to their portfolio in Q3 2025, for an estimated $124,193,833
ARK INVESTMENT MANAGEMENT LLC added 2,186,132 shares (+6072588.9%) to their portfolio in Q3 2025, for an estimated $119,603,281
CAPITAL WORLD INVESTORS removed 2,059,161 shares (-11.3%) from their portfolio in Q3 2025, for an estimated $112,656,698

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

EXAS Analyst Ratings

Wall Street analysts have issued reports on $EXAS in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Piper Sandler issued a "Overweight" rating on 11/11/2025
TD Cowen issued a "Buy" rating on 11/04/2025
Baird issued a "Outperform" rating on 11/04/2025
Evercore ISI Group issued a "Outperform" rating on 10/07/2025
Craig-Hallum issued a "Buy" rating on 09/11/2025

To track analyst ratings and price targets for EXAS, check out Quiver Quantitative's $EXAS forecast page.

EXAS Price Targets

Multiple analysts have issued price targets for $EXAS recently. We have seen 16 analysts offer price targets for $EXAS in the last 6 months, with a median target of $86.5.

Here are some recent targets:

Anthony Petrone from Mizuho set a target price of $105.0 on 01/20/2026
Vijay Kumar from Evercore ISI Group set a target price of $105.0 on 01/05/2026
Kyle Mikson from Canaccord Genuity set a target price of $105.0 on 11/25/2025
Brandon Couillard from Jefferies set a target price of $105.0 on 11/24/2025
Brandon Couillard from Wells Fargo set a target price of $105.0 on 11/21/2025
Luke Sergott from Barclays set a target price of $105.0 on 11/21/2025
David Westenberg from Piper Sandler set a target price of $80.0 on 11/11/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $25,000 of TC ENERGY lobbying was just disclosed

3 weeks, 1 day ago | Jan. 22, 2026 9:59 p.m. UTC

$25,000 of TC ENERGY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Energy and infrastructure"

You can find more data on corporate lobbying on Quiver Quantitative.

TRP Hedge Fund Activity

We have seen 262 institutional investors add shares of TRP stock to their portfolio, and 269 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

GOLDMAN SACHS GROUP INC added 39,624,187 shares (+155.9%) to their portfolio in Q3 2025, for an estimated $2,155,952,014
CLEARBRIDGE INVESTMENTS, LLC added 7,240,870 shares (+648.8%) to their portfolio in Q3 2025, for an estimated $393,975,736
BANK OF MONTREAL /CAN/ removed 6,286,123 shares (-13.8%) from their portfolio in Q3 2025, for an estimated $342,027,952
BANK OF NOVA SCOTIA removed 5,460,982 shares (-32.4%) from their portfolio in Q3 2025, for an estimated $297,132,030
AMERICAN CENTURY COMPANIES INC added 5,435,310 shares (+514.5%) to their portfolio in Q3 2025, for an estimated $295,735,217
MURCHINSON LTD. added 4,050,068 shares (+inf%) to their portfolio in Q3 2025, for an estimated $220,364,199
MONDRIAN INVESTMENT PARTNERS LTD removed 3,505,260 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $190,721,196

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TRP Analyst Ratings

Wall Street analysts have issued reports on $TRP in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

RBC Capital issued a "Outperform" rating on 11/07/2025
CIBC issued a "Outperformer" rating on 11/07/2025
Scotiabank issued a "Sector Outperform" rating on 11/07/2025
Barclays issued a "Overweight" rating on 10/14/2025

To track analyst ratings and price targets for TRP, check out Quiver Quantitative's $TRP forecast page.

TRP Price Targets

Multiple analysts have issued price targets for $TRP recently. We have seen 6 analysts offer price targets for $TRP in the last 6 months, with a median target of $81.0.

Here are some recent targets:

Spiro Dounis from Citigroup set a target price of $82.0 on 11/20/2025
Robert Catellier from CIBC set a target price of $78.0 on 11/07/2025
Robert Hope from Scotiabank set a target price of $81.0 on 11/07/2025
Maurice Choy from RBC Capital set a target price of $84.0 on 11/07/2025
Aaron Macneil from TD Securities set a target price of $81.0 on 10/17/2025
Theresa Chen from Barclays set a target price of $80.0 on 10/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $280,000 of MADRIGAL PHARMACEUTICALS INC. lobbying was just disclosed

3 weeks, 1 day ago | Jan. 22, 2026 6:59 p.m. UTC

$280,000 of MADRIGAL PHARMACEUTICALS INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to CMMI drug pricing Most Favored Nation drug pricing; Issues related to CMMI drug pricing"

You can find more data on corporate lobbying on Quiver Quantitative.

MDGL Insider Trading Activity

MDGL insiders have traded $MDGL stock on the open market 244 times in the past 6 months. Of those trades, 54 have been purchases and 190 have been sales.

Here’s a breakdown of recent trading of $MDGL stock by insiders over the last 6 months:

PAUL A FRIEDMAN has made 0 purchases and 67 sales selling 225,580 shares for an estimated $91,113,997.
BROS. ADVISORS LP BAKER has made 54 purchases buying 165,683 shares for an estimated $61,921,024 and 0 sales.
REBECCA TAUB has made 0 purchases and 52 sales selling 86,001 shares for an estimated $37,654,339.
KENNETH BATE has made 0 purchases and 17 sales selling 26,575 shares for an estimated $11,679,362.
WILLIAM JOHN SIBOLD (President and CEO) has made 0 purchases and 4 sales selling 17,295 shares for an estimated $7,672,313.
RICHARD S LEVY has made 0 purchases and 14 sales selling 8,500 shares for an estimated $4,428,197.
MARDI DIER (EVP and CFO) has made 0 purchases and 15 sales selling 4,173 shares for an estimated $2,413,416.
CAROLE HUNTSMAN (Chief Commercial Officer) has made 0 purchases and 11 sales selling 1,958 shares for an estimated $1,082,986.
SHANNON T KELLEY (General Counsel) has made 0 purchases and 10 sales selling 1,996 shares for an estimated $823,799.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MDGL Hedge Fund Activity

We have seen 189 institutional investors add shares of MDGL stock to their portfolio, and 150 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WELLINGTON MANAGEMENT GROUP LLP added 397,076 shares (+5381.2%) to their portfolio in Q3 2025, for an estimated $182,122,878
JANUS HENDERSON GROUP PLC removed 349,063 shares (-15.9%) from their portfolio in Q3 2025, for an estimated $160,101,235
UBS GROUP AG removed 288,371 shares (-57.0%) from their portfolio in Q3 2025, for an estimated $132,264,242
ADAGE CAPITAL PARTNERS GP, L.L.C. removed 287,663 shares (-76.5%) from their portfolio in Q3 2025, for an estimated $131,939,511
GOLDMAN SACHS GROUP INC added 196,260 shares (+103.4%) to their portfolio in Q3 2025, for an estimated $90,016,611
PAULSON & CO. INC. removed 182,000 shares (-8.7%) from their portfolio in Q3 2025, for an estimated $83,476,120
BAKER BROS. ADVISORS LP added 165,683 shares (+8.4%) to their portfolio in Q3 2025, for an estimated $75,992,164

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MDGL Analyst Ratings

Wall Street analysts have issued reports on $MDGL in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Citizens issued a "Market Outperform" rating on 01/20/2026
HC Wainwright & Co. issued a "Buy" rating on 11/21/2025
Oppenheimer issued a "Outperform" rating on 11/20/2025
Truist Securities issued a "Buy" rating on 11/19/2025
Canaccord Genuity issued a "Buy" rating on 11/13/2025
Cantor Fitzgerald issued a "Overweight" rating on 11/05/2025
Piper Sandler issued a "Overweight" rating on 10/15/2025

To track analyst ratings and price targets for MDGL, check out Quiver Quantitative's $MDGL forecast page.

MDGL Price Targets

Multiple analysts have issued price targets for $MDGL recently. We have seen 12 analysts offer price targets for $MDGL in the last 6 months, with a median target of $603.5.

Here are some recent targets:

Jonathan Wolleben from Citizens set a target price of $745.0 on 01/20/2026
Yasmeen Rahimi from Piper Sandler set a target price of $900.0 on 12/19/2025
William Woods from B. Riley Securities set a target price of $670.0 on 12/11/2025
Andrew S. Fein from HC Wainwright & Co. set a target price of $620.0 on 11/21/2025
Jay Olson from Oppenheimer set a target price of $650.0 on 11/20/2025
Srikripa Devarakonda from Truist Securities set a target price of $640.0 on 11/19/2025
Edward Nash from Canaccord Genuity set a target price of $587.0 on 11/13/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $20,000 of DENTSPLY SIRONA INC. lobbying was just disclosed

3 weeks, 1 day ago | Jan. 22, 2026 6:59 p.m. UTC

$20,000 of DENTSPLY SIRONA INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Competitive bidding for urological products, trace and tariffs"

You can find more data on corporate lobbying on Quiver Quantitative.

XRAY Insider Trading Activity

XRAY insiders have traded $XRAY stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $XRAY stock by insiders over the last 6 months:

GREGORY T LUCIER sold 82,200 shares for an estimated $915,708
LESLIE F VARON purchased 9,337 shares for an estimated $99,999

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

XRAY Hedge Fund Activity

We have seen 223 institutional investors add shares of XRAY stock to their portfolio, and 182 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PRICE T ROWE ASSOCIATES INC /MD/ removed 10,749,500 shares (-98.2%) from their portfolio in Q3 2025, for an estimated $136,411,155
ARMISTICE CAPITAL, LLC added 5,234,587 shares (+1044.0%) to their portfolio in Q3 2025, for an estimated $66,426,909
JACOBS LEVY EQUITY MANAGEMENT, INC added 4,003,606 shares (+662.0%) to their portfolio in Q3 2025, for an estimated $50,805,760
D. E. SHAW & CO., INC. added 1,669,643 shares (+136.1%) to their portfolio in Q3 2025, for an estimated $21,187,769
BRICKWOOD ASSET MANAGEMENT LLP added 1,496,935 shares (+5515.8%) to their portfolio in Q3 2025, for an estimated $18,996,105
INVENOMIC CAPITAL MANAGEMENT LP added 1,425,637 shares (+48.7%) to their portfolio in Q3 2025, for an estimated $18,091,333
RUSSELL INVESTMENTS GROUP, LTD. added 1,153,271 shares (+1163.7%) to their portfolio in Q3 2025, for an estimated $14,635,008

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

XRAY Analyst Ratings

Wall Street analysts have issued reports on $XRAY in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Barrington Research issued a "Outperform" rating on 01/05/2026
UBS issued a "Buy" rating on 08/08/2025

To track analyst ratings and price targets for XRAY, check out Quiver Quantitative's $XRAY forecast page.

XRAY Price Targets

Multiple analysts have issued price targets for $XRAY recently. We have seen 9 analysts offer price targets for $XRAY in the last 6 months, with a median target of $13.0.

Here are some recent targets:

Steven Valiquette from Mizuho set a target price of $14.0 on 01/20/2026
Michael Petusky from Barrington Research set a target price of $14.0 on 01/05/2026
Jeffrey Johnson from Baird set a target price of $12.0 on 12/16/2025
Glen Santangelo from Barclays set a target price of $12.0 on 12/09/2025
Vik Chopra from Wells Fargo set a target price of $12.0 on 11/07/2025
Lilia-Celine Lozada from JP Morgan set a target price of $12.0 on 11/07/2025
Kevin Caliendo from UBS set a target price of $23.0 on 10/28/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $140,000 of HOWMET AEROSPACE INC FORMALLY KNOWN AS ARCONIC INC lobbying was just disclosed

3 weeks, 1 day ago | Jan. 22, 2026 3:58 p.m. UTC

$140,000 of HOWMET AEROSPACE INC FORMALLY KNOWN AS ARCONIC INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 4016 - FY26 Defense Appropriations (Metals Affordability Initiative, National Defense Stockpile); H.R. 3838 / S. 2296 - FY26 NDAA (Specialty Metals, Critical Minerals); H.R. 1 - One Big Beautiful Bill Act (National Defense Stockpile, Industrial Capacity); Forging & Casting Industrial Capacity Critical Materials, IEEPA Tariffs (Reciprocal, Brazil), Agreement on Trade in Civil Aircraft, Section 232 Tariffs (Aluminum, Steel, Critical Minerals, Automotive, Trucks, Aircraft / Engines), USMCA Agreement on Trade in Civil Aircraft, Section 232 (Aircraft / Engines) HR 4016 - FY26 Defense Appropriations (Metals Affordability Initiative, National Defense Stockpile); H.R. 1 - One Big Beautiful Bill Act (National Defense Stockpile, Industrial Capacity) H.R. 1 - One Big Beautiful Bill Act (International / Corporate Tax, Section 45x, R&D, Depreciation, National Defense Stockpile, Industrial Capacity), H.R. 4016 - FY26 Defense Appropriations (Metals Affordability Initiative, National Defense Stockpile), H.R. 3838 / S. 2296 - FY26 NDAA (Specialty Metals, Critical Minerals) H.R. 1 - One Big Beautiful Bill Act (International / Corporate Tax, Section 45x, R&D, Depreciation) Economic Development Heavy Duty NOx Rule (emissions standards), Endangerment Finding and GHG Vehicle Standards (emissions standards, proposed rulemaking)"

You can find more data on corporate lobbying on Quiver Quantitative.

HWM Congressional Stock Trading

Members of Congress have traded $HWM stock 7 times in the past 6 months. Of those trades, 1 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $HWM stock by members of Congress over the last 6 months:

REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 1 purchase worth up to $15,000 on 10/30 and 3 sales worth up to $45,000 on 10/31, 10/30, 08/04.
REPRESENTATIVE BYRON DONALDS has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 10/23, 08/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

HWM Insider Trading Activity

HWM insiders have traded $HWM stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $HWM stock by insiders over the last 6 months:

LOLA FELICE LIN (EVP, CL&CO and Secretary) sold 13,102 shares for an estimated $2,365,073

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

HWM Hedge Fund Activity

We have seen 637 institutional investors add shares of HWM stock to their portfolio, and 541 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO removed 3,074,104 shares (-9.7%) from their portfolio in Q3 2025, for an estimated $603,231,427
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 2,447,458 shares (-17.4%) from their portfolio in Q3 2025, for an estimated $480,264,683
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,110,150 shares (+76.8%) to their portfolio in Q3 2025, for an estimated $414,074,734
BLACKROCK, INC. added 2,092,504 shares (+4.5%) to their portfolio in Q3 2025, for an estimated $410,612,059
JANUS HENDERSON GROUP PLC removed 1,184,362 shares (-12.4%) from their portfolio in Q3 2025, for an estimated $232,407,355
BOSTON PARTNERS removed 1,023,868 shares (-34.1%) from their portfolio in Q3 2025, for an estimated $200,913,617
INVESCO LTD. added 801,093 shares (+12.2%) to their portfolio in Q3 2025, for an estimated $157,198,479

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

HWM Analyst Ratings

Wall Street analysts have issued reports on $HWM in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Citigroup issued a "Buy" rating on 01/13/2026
B of A Securities issued a "Buy" rating on 11/14/2025
JP Morgan issued a "Overweight" rating on 11/10/2025
BTIG issued a "Buy" rating on 11/03/2025
RBC Capital issued a "Outperform" rating on 10/31/2025
TD Cowen issued a "Buy" rating on 10/31/2025
Truist Securities issued a "Buy" rating on 10/15/2025

To track analyst ratings and price targets for HWM, check out Quiver Quantitative's $HWM forecast page.

HWM Price Targets

Multiple analysts have issued price targets for $HWM recently. We have seen 11 analysts offer price targets for $HWM in the last 6 months, with a median target of $227.0.

Here are some recent targets:

John Godyn from Citigroup set a target price of $255.0 on 01/13/2026
Ronald Epstein from B of A Securities set a target price of $250.0 on 11/14/2025
Seth Seifman from JP Morgan set a target price of $227.0 on 11/10/2025
Andre Madrid from BTIG set a target price of $240.0 on 11/03/2025
Noah Poponak from Goldman Sachs set a target price of $226.0 on 11/03/2025
Gavin Parsons from UBS set a target price of $209.0 on 10/31/2025
Ken Herbert from RBC Capital set a target price of $235.0 on 10/31/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $30,000 of ARCHER AVIATION INC. lobbying was just disclosed

3 weeks, 2 days ago | Jan. 22, 2026 4:02 a.m. UTC

$30,000 of ARCHER AVIATION INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Defense Authorization and Appropriations bills, FY-25 and FY-26. Issues related to Hybrid VTOL Aircraft technology development."

You can find more data on corporate lobbying on Quiver Quantitative.

ACHR Insider Trading Activity

ACHR insiders have traded $ACHR stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $ACHR stock by insiders over the last 6 months:

THOMAS PAUL MUNIZ (CHIEF TECHNOLOGY OFFICER) has made 0 purchases and 3 sales selling 301,781 shares for an estimated $2,526,032.
ERIC LENTELL (Chief Legal & Strategy Officer) has made 0 purchases and 2 sales selling 90,426 shares for an estimated $791,975.
TOSHA PERKINS (CHIEF PEOPLE PARTNERSHIPS OFF.) has made 0 purchases and 2 sales selling 87,793 shares for an estimated $757,857.
PRIYA GUPTA (Interim CFO) has made 0 purchases and 2 sales selling 15,703 shares for an estimated $141,560.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ACHR Hedge Fund Activity

We have seen 296 institutional investors add shares of ACHR stock to their portfolio, and 184 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

VANGUARD GROUP INC added 16,452,398 shares (+45.8%) to their portfolio in Q3 2025, for an estimated $157,613,972
D. E. SHAW & CO., INC. removed 15,948,972 shares (-94.6%) from their portfolio in Q3 2025, for an estimated $152,791,151
STATE STREET CORP added 8,495,613 shares (+40.5%) to their portfolio in Q3 2025, for an estimated $81,387,972
CITADEL ADVISORS LLC removed 6,963,031 shares (-80.2%) from their portfolio in Q3 2025, for an estimated $66,705,836
JANE STREET GROUP, LLC removed 4,890,914 shares (-81.3%) from their portfolio in Q3 2025, for an estimated $46,854,956
GOLDMAN SACHS GROUP INC removed 4,722,840 shares (-75.3%) from their portfolio in Q3 2025, for an estimated $45,244,807
MORGAN STANLEY added 4,665,927 shares (+56.5%) to their portfolio in Q3 2025, for an estimated $44,699,580

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ACHR Analyst Ratings

Wall Street analysts have issued reports on $ACHR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Canaccord Genuity issued a "Buy" rating on 11/21/2025
Needham issued a "Buy" rating on 11/07/2025
HC Wainwright & Co. issued a "Buy" rating on 08/12/2025

To track analyst ratings and price targets for ACHR, check out Quiver Quantitative's $ACHR forecast page.

ACHR Price Targets

Multiple analysts have issued price targets for $ACHR recently. We have seen 5 analysts offer price targets for $ACHR in the last 6 months, with a median target of $11.0.

Here are some recent targets:

Chris Pierce from Needham set a target price of $10.0 on 01/14/2026
Anthony Valentini from Goldman Sachs set a target price of $11.0 on 12/01/2025
Austin Moeller from Canaccord Genuity set a target price of $13.0 on 11/21/2025
Bill Peterson from JP Morgan set a target price of $8.0 on 11/07/2025
Amit Dayal from HC Wainwright & Co. set a target price of $18.0 on 08/12/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $75,000 of TWIST BIOSCIENCE CORPORATION lobbying was just disclosed

3 weeks, 2 days ago | Jan. 22, 2026 1:01 a.m. UTC

$75,000 of TWIST BIOSCIENCE CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Gene synthesis screening S.1071 - National Defense Authorization Act for Fiscal Year 2026 H.R.6624/S.3452 - Biological Intellectual Property Protection Act of 2025 Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Robotics and Industrial Machinery (Docket No. 250924-0161 / XRIN 0694-XC138)"

You can find more data on corporate lobbying on Quiver Quantitative.

TWST Insider Trading Activity

TWST insiders have traded $TWST stock on the open market 63 times in the past 6 months. Of those trades, 0 have been purchases and 63 have been sales.

Here’s a breakdown of recent trading of $TWST stock by insiders over the last 6 months:

EMILY M. LEPROUST (Chief Executive Officer) has made 0 purchases and 11 sales selling 86,883 shares for an estimated $2,700,762.
PATRICK JOHN FINN (President and COO) has made 0 purchases and 10 sales selling 78,870 shares for an estimated $2,677,729.
ADAM LAPONIS (Chief Financial Officer) has made 0 purchases and 8 sales selling 24,452 shares for an estimated $802,779.
PAULA GREEN (SVP of Human Resources) has made 0 purchases and 11 sales selling 22,677 shares for an estimated $706,331.
DENNIS CHO (See Remarks) has made 0 purchases and 12 sales selling 14,915 shares for an estimated $461,790.
ROBERT F. WERNER (Chief Accounting Officer) has made 0 purchases and 10 sales selling 6,010 shares for an estimated $181,133.
JAN JOHANNESSEN sold 7,044 shares for an estimated $174,479

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TWST Hedge Fund Activity

We have seen 135 institutional investors add shares of TWST stock to their portfolio, and 102 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

EDGEPOINT INVESTMENT GROUP INC. added 1,696,377 shares (+71.1%) to their portfolio in Q3 2025, for an estimated $47,736,048
POINT72 ASSET MANAGEMENT, L.P. removed 1,628,357 shares (-75.4%) from their portfolio in Q3 2025, for an estimated $45,821,965
SOLEUS CAPITAL MANAGEMENT, L.P. added 1,511,833 shares (+426.6%) to their portfolio in Q3 2025, for an estimated $42,542,980
THRIVENT FINANCIAL FOR LUTHERANS added 1,456,368 shares (+21681.8%) to their portfolio in Q3 2025, for an estimated $40,982,195
CITADEL ADVISORS LLC removed 1,388,301 shares (-92.3%) from their portfolio in Q3 2025, for an estimated $39,066,790
ARTISAN PARTNERS LIMITED PARTNERSHIP added 1,349,867 shares (+26.7%) to their portfolio in Q3 2025, for an estimated $37,985,257
MILLENNIUM MANAGEMENT LLC added 1,080,722 shares (+151.5%) to their portfolio in Q3 2025, for an estimated $30,411,517

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TWST Analyst Ratings

Wall Street analysts have issued reports on $TWST in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Barclays issued a "Overweight" rating on 11/17/2025
Evercore ISI Group issued a "Outperform" rating on 10/07/2025

To track analyst ratings and price targets for TWST, check out Quiver Quantitative's $TWST forecast page.

TWST Price Targets

Multiple analysts have issued price targets for $TWST recently. We have seen 4 analysts offer price targets for $TWST in the last 6 months, with a median target of $41.5.

Here are some recent targets:

Brendan Smith from TD Cowen set a target price of $43.0 on 01/08/2026
Luke Sergott from Barclays set a target price of $39.0 on 12/15/2025
Steven Etoch from Stephens & Co. set a target price of $41.0 on 11/04/2025
Vijay Kumar from Evercore ISI Group set a target price of $42.0 on 10/07/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Lobbying Update: $90,000 of TRIPADVISOR LLC lobbying was just disclosed

3 weeks, 2 days ago | Jan. 21, 2026 10:03 p.m. UTC

$90,000 of TRIPADVISOR LLC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to travel and technology. Issues around Section 230 of the Communications Decency Act of 1996. Issues related to online trust and safety. Issues related to Artificial Intelligence. The Hotel Fee Transparency Act, S.314/H.R. 1479. TICKET Act, S. 281. Issues related to Children's Online Safety. Issues around Section 230 of the Communications Decency Act of 1996. Issues related to treatment of metasearch sites and consumers in the travel industry. Issues related to competition in the travel and technology industries. Issues related to treatment of metasearch sites and consumers in the travel industry; issues related to online consumer reviews; The Hotel Fee Transparency Act, S.314/H.R. 1479."

You can find more data on corporate lobbying on Quiver Quantitative.

TRIP Insider Trading Activity

TRIP insiders have traded $TRIP stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $TRIP stock by insiders over the last 6 months:

KRISTEN ANN DALTON (President, Brand Tripadvisor) sold 18,000 shares for an estimated $269,640
SETH J KALVERT (Chief Legal Officer & Sec.) sold 10,880 shares for an estimated $218,004
ALMIR AMBESKOVIC (CEO, TheFork) has made 0 purchases and 2 sales selling 4,115 shares for an estimated $65,105.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TRIP Hedge Fund Activity

We have seen 146 institutional investors add shares of TRIP stock to their portfolio, and 154 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BALYASNY ASSET MANAGEMENT L.P. removed 2,278,131 shares (-99.5%) from their portfolio in Q3 2025, for an estimated $37,042,410
FIL LTD removed 1,919,584 shares (-42.8%) from their portfolio in Q3 2025, for an estimated $31,212,435
CITADEL ADVISORS LLC removed 1,688,054 shares (-62.6%) from their portfolio in Q3 2025, for an estimated $27,447,758
BANK OF AMERICA CORP /DE/ removed 1,683,664 shares (-85.6%) from their portfolio in Q3 2025, for an estimated $27,376,376
ALYESKA INVESTMENT GROUP, L.P. added 1,651,184 shares (+inf%) to their portfolio in Q3 2025, for an estimated $26,848,251
ROYAL BANK OF CANADA added 1,552,739 shares (+94.2%) to their portfolio in Q3 2025, for an estimated $25,247,536
AMERIPRISE FINANCIAL INC added 1,445,607 shares (+24.2%) to their portfolio in Q3 2025, for an estimated $23,505,569

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TRIP Analyst Ratings

Wall Street analysts have issued reports on $TRIP in the last several months. We have seen 0 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

Barclays issued a "Underweight" rating on 11/07/2025
Mizuho issued a "Underperform" rating on 09/30/2025

To track analyst ratings and price targets for TRIP, check out Quiver Quantitative's $TRIP forecast page.

TRIP Price Targets

Multiple analysts have issued price targets for $TRIP recently. We have seen 7 analysts offer price targets for $TRIP in the last 6 months, with a median target of $17.0.

Here are some recent targets:

Deepak Mathivanan from Cantor Fitzgerald set a target price of $14.0 on 01/08/2026
John Colantuoni from Jefferies set a target price of $12.5 on 12/11/2025
Lloyd Walmsley from Mizuho set a target price of $17.0 on 11/14/2025
Naved Khan from B. Riley Securities set a target price of $18.0 on 11/10/2025
Trevor Young from Barclays set a target price of $13.0 on 11/07/2025
Ronald Josey from Citigroup set a target price of $19.0 on 08/18/2025
Stephen Ju from UBS set a target price of $18.0 on 07/28/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read Full Article

Quiver News

NMAX Hedge Fund Activity

NMAX Analyst Ratings

AXGN Insider Trading Activity

AXGN Hedge Fund Activity

AXGN Analyst Ratings

AXGN Price Targets

SHOP Congressional Stock Trading

SHOP Hedge Fund Activity

SHOP Analyst Ratings

SHOP Price Targets

CDE Insider Trading Activity

CDE Hedge Fund Activity

CDE Analyst Ratings

CDE Price Targets

KRC Hedge Fund Activity

KRC Analyst Ratings

KRC Price Targets

FRHC Insider Trading Activity

FRHC Hedge Fund Activity

AXGN Insider Trading Activity

AXGN Hedge Fund Activity

AXGN Analyst Ratings

AXGN Price Targets

SRTS Insider Trading Activity

SRTS Hedge Fund Activity

SRTS Analyst Ratings

EML Insider Trading Activity

EML Hedge Fund Activity

ONTO Hedge Fund Activity

ONTO Analyst Ratings

ONTO Price Targets

RYN Insider Trading Activity

RYN Hedge Fund Activity

RYN Price Targets

CRMD Insider Trading Activity

CRMD Hedge Fund Activity

CRMD Analyst Ratings

CRMD Price Targets

MDXG Insider Trading Activity

MDXG Hedge Fund Activity

MDXG Analyst Ratings

MDXG Price Targets

TXN Congressional Stock Trading

TXN Insider Trading Activity

TXN Hedge Fund Activity

TXN Analyst Ratings

TXN Price Targets

CDNA Insider Trading Activity

CDNA Hedge Fund Activity

CDNA Analyst Ratings

CDNA Price Targets

TAL Hedge Fund Activity

BCO Congressional Stock Trading

BCO Insider Trading Activity

BCO Hedge Fund Activity

DBD Insider Trading Activity

DBD Hedge Fund Activity

DBD Analyst Ratings

DBD Price Targets

RCL Congressional Stock Trading

RCL Insider Trading Activity

RCL Hedge Fund Activity

RCL Analyst Ratings

RCL Price Targets

PCG Congressional Stock Trading

PCG Insider Trading Activity

PCG Hedge Fund Activity

PCG Analyst Ratings

PCG Price Targets

SLF Hedge Fund Activity

SLF Analyst Ratings

SLF Price Targets

EU Insider Trading Activity

EU Hedge Fund Activity

EU Analyst Ratings

PWR Congressional Stock Trading

PWR Insider Trading Activity

PWR Hedge Fund Activity

PWR Analyst Ratings